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Abstract
The fidelity with which DNA polymerases replicate the synthetic 
polynucleotide polydA.oligodT, can be determined in vitro by measuring 
the ratio of incorporation of non-complementary nucleotides and 
complementary nucleotides into polymeric material. In order to study the 
effect of in vivo or in vitro administration of various genotoxic agents 
on the activity and fidelity of DNA polymerases associated with DNA 
repair, adult rat liver nuclear extracts were used as a source of DNA 
polymerase activity. Endogenous DNA in nuclear extracts did not interfere 
with fidelity studies since no DNA polymerase activity was detectable in 
the absence of polydA.oligodT. Extracts were shown to contain almost 
exclusively DNA polymerase fl (the putative mammalian DNA repair enzyme) 
by the use of differential inhibitors of DNA polymerases. However, DNA 
polymerase B fidelity in nuclear extracts was almost 10-fold lower than 
the fidelity measured for some purified DNA polymerases.
In vitro modification of DNA polymerase B activity in nuclear 
extracts by increasing concentrations of the alkylating agents, methyl 
methane sulphonate (l-400mM) B-propiolactone (1-lOOmM) and 
N-methyl-N-nitro-N-nitrosoguanidine (l-20mM) resulted in a gradual 
inactivation of the enzyme. A similar effect was observed upon treatment 
of the enzyme with anti(±)BPDE. The addition of these agents to nuclear 
extracts appeared to enhance the fidelity of DNA polymerase B activity.
In vivo administration of methyl methane sulphonate also resulted in 
an inhibition of DNA polymerase B activity in nuclear extracts but no 
change in fidelity was observed. In vivo administration of a series of 
N,-N-dialkylnitrosamines generally resulted in an increase in the total 
DNA polymerase B activity in rat liver nuclei. Dimethylnitrosamine and 
diethylnitrosamine appeared to induce an error-prone DNA polymerase 
activity whereas longer alkyl derivatives, dipropylnitrosamine and 
dibutylnitrosamine did not. Similarly in vivo administration of 2 toxic 
doses of benzo(a)pyrene to rats 48h and 24h before killing resulted in an 
increase in DNA polymerase B activity in rat liver nuclei.
A single dose of benzo(a)pyrene depressed total DNA polymerase B 
activity in nuclei for up to 14 days. The benzo(a)pyrene treatments used 
in these studies failed to induce an error-prone DNA polymerase activity 
in rat liver nuclei.
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CHAPTER 1
GENERAL INTRODUCTION
1.1 MAINTENANCE OF THE GENETIC CODE.
The replication of DNA during 'S' phase DNA synthesis or during DNA
repair (unscheduled DNA synthesis), must be highly accurate to ensure
species identity. However, spontaneous mutations are necessary to provide
species diversity and also for adaptation to a changing environment.
When Watson and Crick elucidated the structure of DNA in 1953, they
suggested that the faithful replication of the base sequence was mediated
primarily by hydrogen bonding between parental DNA and daughter
nucleotides. During DNA synthesis in vivo, the stable misincorporation of
nucleotides into DNA (that is, the insertion of a daughter nucleotide
which is non-complementary to the parental nucleotide according to the
Watson-Crick base-pairing scheme), has been calculated, from spontaneous
mutation rates, to occur at a frequency of 10~^ to 10~^ per base
pair synthesized (Drake, 1969). Similar studies on the reversion
frequencies of 'phage 4>X174 in Escherischia coli have shown base
-9misincorporation frequencies of around 10 (Weymouth and Loeb, 1978).
Unfaithful DNA synthesis during DNA replication and DNA repair or the 
replication of damaged DNA may lead to high mutation rates, cell death or 
even cancer. Thus the cell has several mechanisms which contribute to the 
fidelity of the genetic coding process:
1. Removal of DNA damage by DNA repair enzymes.
2. Nucleotide selection by DNA polymerases and enhancement of fidelity
by associated proteins.
3. Removal of non-complementary nucleotides from DNA by exonucleases.
4. Post replicative excision of mismatched bases by specific 
endonucleases and exonucleases.
In the following sections of this chapter, mammalian DNA repair
processes, which have evolved to cope with a variety of DNA damage are 
outlined. The involvement of cellular DNA polymerases in the fidelity of 
DNA replication and repair are also reviewed. Finally, the possible 
involvement of DNA polymerases and DNA repair in mutagenesis is discussed.
1.2 ORIGINS OF DNA DAMAGE
DNA damage has been defined by Hanawalt et al., (1979) as any
modification of DNA that alters its coding properties or its normal
function in replication or transcription.
Damage arising spontaneously in DNA
A mammalian cell is postulated to lose about 10000 purines and 500
pyrimidines from its DNA during a 20 hour generation period by
spontaneous hydrolysis at 37°C (Lindahl, 1977). Apurinic and 
apyrimidinic sites thus formed are labile but last about 100 hours in DNA 
at 37°C before chain breakage occurs (Lindahl and Andersson, 1972).
Spontaneous hydrolysis of nucleotides occurs in DNA at neutral pH. 
Deamination of cytosine to uracil (figure 1.1a) is not very prolific in 
native DNA, but occurs mainly in single-stranded DNA. Approximately 1% of 
nuclear DNA is in this state due to transcription, replication and 
constraints in superhelical DNA (Lindahl, 1977).
Small amounts of 5-methyl cytosine in DNA undergo spontaneous 
deamination to thymine (figure 1.1b) and adenine deaminates to 
hypoxanthine (figure 1.1c) (Coulondre et al., 1978; Jones et_ al., 1966). 
Minor spontaneous lesions arise from imidazole ring opening in adenine 
(Garrett and Mehta, 1972); the conversion of deoxyguanosine to 
neodeoxyguanosine (Lindahl, 1977 (figure l.ld)) and the hydration of 
pyrimidines (Hauswirth et al., 1972).
Damage caused by Genotoxic compounds
Many chemical carcinogens and chemical mutagens belong to the class 
of agents known as genotoxic compounds. These compounds produce toxic, 
lethal and heritable effects on the genetic material in germinal and 
somatic cells.
The diverse structures of chemical carcinogens and mutagens (figure 
.1.2) and the observation that many of these chemicals are inactive until 
converted by metabolism to their active forms, gave rise to the concept 
that the ultimate carcinogenic and mutagenic forms of these compounds are 
strong electrophilic reactants (Miller and Miller, 1966; Miller, 1970). 
Mutagens and carcinogens which do not require metabolic activation 
already possess electrophilic properties (figure 1.3). In most instances, 
the enzymes involved in metabolic activation are the mixed function 
oxidases of the endoplasmic reticulum. These enzymes are NADPH-dependent 
and consist of an electron transporting system, together with a terminal
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cytochrome, known as cytochrome P450 (Gillette et al., 1972). The
substrate specificity appears to reside in cytochrome P450, which is 
inducible, and there is evidence that this haemoprotein exists in 
multiple forms within a tissue (Conney, 1967; Ulrich and Kremers, 1977). 
Metabolic activation of carcinogens and mutagens has been reviewed in 
detail (Weisburger and Williams, 1975), and will not be discussed here.
The electrophilic species of genotoxic chemicals can normally undergo 
some type of covalent interaction with DNA; thus nucleophilic centres on 
all four bases, on deoxyribose and on the phosphodiester backbone, are 
all available for reaction . The sites of reaction known to date of some 
genotoxic agents with DNA are shown in figure 1.4. The reactions of some 
simple alkylating agents, the dialkylnitrosamines and benzo(a)pyrene 
metabolites with DNA are discussed in more detail in sections 4.1 and 5.1 
respectively. Other reactions with DNA involve intrastrand cross-linking 
by nitrogen and sulphur mustards; interstrand cross-linking (in the 
presence of sulphur mustards) and phosphotriester formation (Sarma et 
al., 1975; Shooter, 1976).
Certain genotoxic agents may also bind DNA non-covalently through 
intercalation (Sarma et al., 1975). Typical intercalating agents usually 
have a planar geometry such as the polycyclic aromatic hydrocarbons 
(Boyland, 1969). There is also some recent evidence to suggest that
intercalating agents cause double-strand breaks in DNA (Ross and Bradley, 
1981).
Damage caused by radiation
The major lesion formed in DNA following exposure to UV-irradiation 
is the formation of a cyclobutane derivative between adjacent thymidine
or deoxycytidine residues in the DNA chain, also known as pyrimidine
dimers (Setlow, 1968).
Exposure to ionizing radiation gives rise to ring contraction,
fragmentation and elimination products, probably as a result of the 
generation of hydroxyradicals. The apurinic and apyrimidinic sites which 
often result from these processes may eventually give rise to single and 
double strand breaks (Brash and Hart, 1978; Kanazir, 1969).
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1.3 DNA REPAIR PROCESSES
The cellular repair of damage to a macromolecule is only known for 
DNA and in no other instance is the integrity of a single molecule so 
vital to the survival of the cell. The consequences of various types of 
damage to DNA are shorn in table 1.1. Damage to RNA and protein can be 
tolerated more readily since they are generally turned over more quickly 
and exist in multiple copies.
DNA repair was initially observed in bacteria and most of the 
bacterial repair systems so far elucidated have mammalian counterparts. 
Only brief accounts of repair processes existing in mammalian cells are 
given here as there are several excellent reviews available in the 
literature (Hanawalt et al., 1979; Grossman, 1981; Verly, 1980; Schendel, 
1981).
(a) Photoreactivation
Photoreactivation was first discovered in bacteria (Sutherland et^  
al., 1973) and was later reported to occur in mammalian cells (Sutherland 
et al., 1974; Sutherland et al., 1980). It is specific for the removal of 
UV-induced pyrimidine dimers from DNA by reversal of the dimerization 
process, mediated in visible light by the photoreactivation enzyme 
(photolyase), which binds to the dimer in the dark. This process is 
thought to be of minor importance in the repair of pyrimidine dimers by 
mammalian cells.
(b) Excision-repair
Excision-repair is probably the most widespread type of repair 
process in mammalian cells, which copes with a wide spectrum of DNA
damage. It involves the interaction of multicomponent enzyme systems. 
Damage is thought to be recognized by repair enzymes due to the
distortional effects of damaging agents on the DNA helix (Cerutti, 1975), 
and repair is essentially error-free (Lieberman, 1976).
Nucleotide excision-repair
Damaged nucleotides in DNA are recognized by specific endonucleases,
which introduce a nick in the phosphodiester backbone, adjacent to the
site of damage or downstream of the damage. Subsequent exonuclease action 
(3' to 5‘, or 5' to 3') then releases the damaged nucleotide along with
Table 1.1
Possible consequences of unrepaired damage to DNA
Agent
UV-irradiation 
X-,y-irradiation
Simple alkylating 
agents 
(e.g.MNNG)
Alkylating agents with 
bulky substituents 
(e.g. N-acetoxyacetyl- 
fluorene)
Bifunctional alkylating 
agents 
(e.g. Nitrogen and 
sulphur mustards)
Intercalating agents
Lesion
pyrimidine dimer
strand-breakage 
depurination 
base-modification
base modification 
(at base-pairing sites)
Base modification
Interst rand/Intrast rand 
crosslinking
DNA helix unwinding
Effect
replication and 
transcription block
deletions
miscoding
miscoding
miscoding
Replication and 
transcription block
Replication and 
transcription block
Frame-shift
mutations;
miscoding
Spontaneous damage cytosine uracil GC —> AT transition
5-methylcytosine->uracil GC ->AT transition 
adenine—>hypoxanthine AT -> GC transition
other nucleotides from the damaged DNA to produce a repair patch, the 
size of which depends on the nature of the damage. Repair patches in 
mammalian cells have been shown to be as short as 3-4 nucleotides in the 
repair of X-ray induced damage (Painter and Young, 1972). Long patch 
repair involves the excision of up to 100 nucleotides (Regan and Setlow, 
1974). A DNA polymerase then inserts the correct nucleotide sequence 
using the undamaged DNA strand as template. Finally, a polynucleotide 
ligase seals the gap between the 5' phosphate group and the adjacent 3' 
hydroxy group of the preceding nucleotide (figure 1.5).
Nucleotide excision-repair appears to be responsible for the removal 
of nucleotides modified by bulky substituents from, for example 
N-acetoxyacetylaminofluorene (Ahmed and Setlow, 1977),
7-bromomethylbenzanthracene (Lieberman and Dipple, 1972), benzo(a)pyrene 
and pyrimidine dimers (Regan et al., 1978). The presence of these adducts 
and pyrimidine dimers cause major helix distortion, due in most cases to 
fixing of bases in an unnatural conformation. These products act as an 
absolute block to DNA synthesis if not repaired (Hanawalt et al., 1979).
Base excision-repair
Base excision-repair involves the removal of modified or damaged 
bases, which may form non-complementary base-pairs in DNA, by DNA 
glycosylase activity. DNA glycosylases catalyse the cleavage of 
sugar-base bonds in DNA. The resultant apurinic or apyrimidinic site is 
then recognised by an endonuclease and repair proceeds as described in 
nucleotide excision-repair (Verly et al., 1981; Warner et al., 1980; Nes,
1980).
A number of DNA glycosylases have been isolated or identified in 
mammalian cells. Uracil DNA glycosylase is specific for the removal of 
uracil from DNA (Lindahl, 1976; Si rover, 1979) which may arise 
spontaneously through deamination of cytosine or by the incorporation of 
deoxyuridine triphosphate into DNA by DNA polymerases (dUTP may be 
incorporated in the absence of dUTPase activity as it is a competitor 
with dTTP (Yoshida and Masaki, 1979). The enzyme does not however remove 
thymine produced from 5-methyl cytosine. Although uracil does not disrupt 
the Watson-Crick base pairing scheme it may induce G-C to A-T transitions 
(Warner and Duncan, 1978).
Hypoxanthine DNA glycosylase is responsible for the removal of the 
product of adenine deamination but not for the removal of related bases 
such as xanthine (Myrnes et al.., 1982).
Excision repair of DNA damage
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The major lesion formed in DNA following attack by alkylating agents 
is 7-alkyl guanine. This base has been shown not to have miscoding 
properties in vitro (Ludlum, 1970) but at neutral pH undergoes 
spontaneous hydrolysis to yield an apurinic site. A much slower reaction 
however in vivo is its conversion to the ring-opened form, 2,6 
-diamino-4-oxy-5-N-methyl formamido pyrimidine (Chetsanga et al., 1981) . 
The coding or non-coding properties of this lesion are unknown, however a 
specific glycosylase for its removal has been detected in rodent cell 
extracts (Margison and Pegg, 1981).
Another major product of attack of alkylating agents on DNA is 
3-methyl adenine. Although this modified base has not been shown to cause 
miscoding in vitro (Margison and O'Connor, 1979) alkylation at this 
position causes major helix distortion and thus acts as a block to DNA 
replicative enzymes (Cerutti, 1975). 3-methyl adenine DNA glycosylase has 
been isolated from a number of bacterial and mammalian sources (Gombar et 
al., 1981; Cathcart and Goldthwait, 1981; Singer and Brent, 1981).
DNA insertase activity
Apurinic sites resulting during the course of base-excision repair or 
which arise spontaneously in DNA may be repaired by the action , of an 
'insertase'. Deutsch and Linn (1979) have reported the partial 
purification from human fibroblasts of an enzyme activity that inserts 
purine bases into depurinated DNA. But this activity has not been shown 
to insert pyrimidines into apyrimidinic sites.
(c) Strand-break repair
Single-strand breakage in DNA arises following exposure to ionizing, 
radiation and in the course of other DNA repair processes. Simple 
phosphodiester bond scission is subject to direct ligation by 
polynucleotide ligase (Hanawalt et al., 1979). However, where strand
scission occurs concurrently with damage to nucleotides then 
excision-repair takes place (Painter and Young, 1972). Double-strand 
breaks may be produced directly as a result of ionizing radiation or as a 
result of single-strand breaks being directly opposed to each other. 
Again repair is usually by direct ligation but repair of double-strand 
breaks in bacteria has been reported to involve recombination-like 
events, particularly in the case of Micrococcus radiodurans which is 
remarkably insensitive to X-irradiation (Krasin and Hutchinson, 1977).
Repair of double-strand breaks has been reported in mammalian cells but
the mechanism is nuclear due to the complex structure of mammalian DNA
(Corry and Cole, 1973; Lehmann and Stevens, 1977).
(d) DNA cross-link repair
Covalent intrastrand cross-links pose absolute blocks to DNA
replication and transcription in mammalian cells. The exact mode by which 
cross-links are repaired is not known but Cleaver (1978) has proposed 
that opposite ends of cross-links are treated in different manners. On 
one strand of DNA, the first arm of the cross-link is removed by a 
glycosylase activity and on the other strand, the remaining structure is 
removed by excision. However, because opposite strands are undergoing 
repair at the same time, the template for DNA polymerase activity will 
not be undamaged and may therefore lead to errors in the repair process.
(e) Post-replication repair
Post-replication repair is the general name given to processes by 
which mammalian cells cope with damage in DNA whilst replication is 
taking place. In effect it is not a repair process since damage is not
removed, but is a means by which cells can complete DNA synthesis by 
circumventing DNA damage (Lehmann, 1974).
A constitutive post-replication repair system has been shown to exist 
both in bacteria and mammalian cells (Ganesan, 1974; Lehmann et al.,
1977) in which cells exposed to UV-irradiation or carcinogens initially 
synthesize DNA in short strands, since synthesis stops at the site of 
damage, but in time recover to produce high molecular weight DNA. The 
mechanism of recovery is obscure but gap-filling has been shown to result 
from sister-strand recombinational exchanges of large amounts of DNA in 
bacteria (Rupp et al., 1971). The extent to which recombination takes 
place in mammalian cells is unknown. Gap-filling may also involve de-novo 
DNA synthesis. The nature of products inserted opposite damaged regions 
is not clear.
Adaptive and inducible repair responses
The adaptive response to DNA damaging agents was first observed in 
E.coli (Robins and Cairns, 1979; Cairns et al., 1981). Enhanced survival 
and lower mutation frequencies were observed following exposure to lethal 
concentrations of MNNG in cells which had previously been exposed to 
sublethal concentrations of MNNG (adapted cells), when compared to cells
which were not adapted (Sklar and Strauss, 1980). Similar adaptive 
responses have been observed in mammalian cells for the removal of
0-6-methyl guanine (Montesano e_t al., 1979; Buckley et al., 1979; Renard 
and Verly, 1980; Chu et al., 1981). The molecular mechanism of the
adaptive response is unknown. In mammalian cells, the removal of
0-6-methyl guanine does not appear to be an excision-repair process but 
may involve transfer of the alkyl group from 0-6 to cysteine in a 
so-called alkyl acceptor protein (Mehta et al., 1981). Adaptation may
involve the induction of such an activity.
Another inducible repair process is known as the 'SOS' response which 
involves replication of DNA containing damaged regions (Howard-Flanders, 
1981). This process is mutagenic in both bacterial and mammalian cells.
The 'SOS' response appears to be induced in bacteria by the presence of
bulky lesions or non-pairing lesions in the DNA which arrest DNA
synthesis; or as a result of overlapping gaps in the daughter strands 
which cannot be repaired by a recombinational system (Witkin, 1976; 
Radman et aj^ ., 1977). Induction of the process in bacteria seems to
require proteolysis. Protease activity may result in cleavage of
repressors for certain cellular genes which are thus switched on. 'SOS' 
induction in E.coli is accompanied by the appearance of X protein which 
is the rec A gene product (Witkin, 1976) but can be inhibited by the 
protease inhibitor, antipain (Radman et al., 1977). The trigger for
proteolysis is unknown.
Several lines of evidence are available to show that the 'SOS' 
response is error-prone. As early as 1953, Weigle observed that when 
E.coli cells were exposed to a low ultraviolet dose and were then
infected with UV-irradiated 'phage <|>X174, the survival of the 'phage 
was higher in treated host than in untreated host. However the 
reactivated 'phage was heavily mutated. This phenomenon was known as 
Weigle reactivation. Sarasin and Hanawalt (1978) later showed the 
enhanced survival of radiation-treated SV-40 virus in CV-1P monkey kidney 
cells which had been pre-treated with various carcinogens. The 
reactivated SV-40 virus however was highly mutated. Protein synthesis is 
also necessary for the induction of the 'SOS' response in mammalian cells 
(D'Ambrosio and Setlow, 1976).
The mechanism of virus reactivation in these systems is unknown but 
it appears that the DNA polymerase responsible for replication of damaged 
virus in the mammalian system is error-prone (Das Gupta and Summers, 
1978; Noy and Weissbach, 1977; see also section 1.6).
Mismatch repair
Mismatch repair involves the removal of replication errors from DMA. 
Single base-pair mismatches are recognized by an endonuclease and repair 
proceeds as in nucleotide excision-repair (Loeb and Kunkel, 1982). 
Recognition of mispaired bases in newly synthesized daughter strands is 
due to transient undermethylation of the daughter DNA chains (Wagner and 
Meselson, 1976; Glickman and Radman, 1980). Daughter strand recognition 
in bacteria seems to be dependent on the presence of N-6-methyl adenine 
in GATC sequences (Loeb and Kunkel, 1982). The recognition signal in 
mammalian cells is presently unknown.
The involvement of DNA repair in the carcinogenic process has been 
implicated by the finding that in certain clinical conditions which show 
DNA repair defects, the patients may be cancer prone (Cleaver, 1980 and
1978). The best known example is xeroderma pigmentosum, were there is a 
high incidence of skin carcinomas and melanomas which correlates with the 
inability to repair UV-induced DNA damage (Setlow et. al., 1977). Other 
clinical syndromes in which there is a particular repair defect are 
outlined in table 1.2.
Table 1.2.
Clinical syndromes showing DNA repair defects
Disease Agent Proposed repair 
defect
Neoplastic
disease
Xeroderma
pigmentosum
UV-irradiation Excision repair
alkylating agents
Skin
carcinoma
Melanoma
XP variant UV-irradiation Post replication
repair
Skin
carcinoma
Melanoma
Ataxia X-,y-irradiation Excision repair Lymphoma
telangiectasia MNNG
Fanconi's 
anaemia
cross-linking
agents
Exonuclease
activity
Leukaemia
Bloom's syndrome UV-irradiation 
EMS
Recombination Leukaemia
Retinoblastoma X-irradiation Unknown Retino­
blastoma
Taken from: Cleaver,(1980);
Weichselbaum and Little,(1980)
1.4 DNA POLYMERASES AND THEIR INVOLVEMENT IN DNA REPLICATION AMD
REPAIR
Since DNA polymerase activity was first demonstrated in mammalian
cells in the late 1950’s (Bollum, 1958), the existence of multiple
species of DNA polymerases in mammalian cells has been established. It is
now generally accepted that there are at least three diferent classes of
DNA polymerases in mammalian cells, a, B and y, named in order of
discovery. All DNA polymerases so far isolated appear to be zinc
metalloenzymes which require a template, an oligonucleotide primer
(hydrogen bonded to the template), with a 3'-hydroxy terminus,
deoxynucleoside triphosphates and a divalent metal cation (probably 
2+Mg in vivo) for polymerization to take place (Loeb, 1974). Different 
classes of DNA polymerase may be distinguished on the basis of size, 
subcellular location, pH optimum, activation or inhibition by salt, 
template preference and by susceptibility to various classes of 
inhibitors (Dube et al., 1978; Dube et al., 1979).
DNA polymerase a has a nuclear location although in early attempts 
at purification it was found to be located in the cytoplasmic compartment 
(see chapter 3). This activity is predominant in growing cells forming up 
to 90% of the total cell DNA polymerase content (Weissbach, 1975). The 
enzyme has now been isolated from a variety of sources, for example, calf 
thymus (Grosse and Krauss, 1980), human KB cells (Fisher and Korn, 1981), 
human placenta (Krauss and Linn, 1980; Seal et al., 1979), regenerating 
rat liver (Mechali et al., 1980), HeLa cells (Weissbach et al., 1971) and 
in certain tissues has been shown to exist in multiple forms (Krauss and 
Linn, 1980; Chan and Becker, 1980). To date, no polymerase in this class 
has been shown to have exoriuclease activity (which is typical in 
prokaryotic counterparts). However, DNA polymerase a from calf thymus 
does perform limited pyrophosphate exchange and pyrophosphorolysis (Chang 
and Bollum, 1973).
DNA polymerase B has a nuclear location and forms about 5-15% of the 
total DNA polymerase activity in growing cells (Weissbach, 1975). DNA 
polymerases B isolated to date have all been shown to exist as a single 
polypeptide chain with molecular weights between 40 and 45 kilodaltons 
(Tanabe et^  al^ ., 1981). Like DNA polymerase a, the enzyme does not
contain any exonuclease activity, but also does not catalyse 
pyrophosphorolysis and pyrophosphate exchange (Chang and Bollum, 1973). 
DNA polymerase B from various sources has been shown to have high degrees
of cross-reactivity (Chang et al., 1982). There is no cross-reaction
however with DNA polymerase a. The existence of multiple forms of DNA 
polymerase R has also been demonstrated (Krauss and Linn, 1980).
DNA polymerase y occurs both in the cytoplasm and in the nucleus 
and forms less than 1% of the total cellular DNA polymerase activity 
(Sarngadharan et al., 1978). It is thought to be identical to the DNA 
polymerase which has been isolated from the mitochondria of various 
tissues (Adams and Kalf, 1980).
A fouth type of DNA polymerase, type 6, has been isolated from calf 
thymus ( Lee et al., 1980) and from rabbit erythroid hyperplastic
bone marrow (Byrnes et al., 1976). These enzymes have similar sensitivity 
to inhibitors as DNA polymerase a, but are the only mammalian DNA 
polymerases so far isolated which have an integral 3'-5' exonuclease 
activity (Byrnes et a^ L., 1977). Radman et al., (1978) have suggested that 
these enzymes are a complex of DNA polymerase a and a mammalian 3'-6' 
exonuclease; however this is unlikely as the activities appear to be 
chromatographically inseperable in the case of the enzyme described by 
Byrnes et al. (1976).
A DNA polymerizing activity, known as terminal deoxynucleotidyl
transferase, has been detected in calf-thymus (Chang, 1971), human 
lymphoblasts (Deibel and Coleman, 1980) and in bone marrow (Sarngadharan 
et al., 1978). Although similar to other DNA polymerases in that they 
appear to be zinc metalloenzymes requiring divalent metal cations for 
polymerization, they are not strictly DNA polymerases however, since they 
do not require a template and can direct synthesis of
polydeoxynucleotides by random addition of deoxynucleoside triphosphates 
onto a primer oligodeoxynucleotide greater than 4 nucleotides in length.
The assignment of roles to each of the cellular DNA polymerases in 
replication and repair of DNA in mammalian cells has been difficult since 
unlike in bacteria, DNA polymerase mutants are unknown. Most information 
has been obtained by making use of differential inhibitors of the various 
DNA polymerases and also by measurement of the activities at various 
stages in the cell cycle.
Several lines of evidence implicate DNA polymerase a as the enzyme
involved in 'S' phase DNA synthesis. The levels of this enzyme are 
highest during this phase of the cell cycle (Wist, 1979) and cells which 
have been stimulated to replicate, by partial hepatectomy or by
stimulation with mitogens, show increased DNA polymerase a activity 
(Chiu et al., 1974; Lynch et^  al., 1975; Bertazzoni et al.., 1976). The 
localization of DNA polymerase a in nuclei of sea urchins at the time 
of cell replication was demonstrated by Loeb (1969). Also, the decline in
DNA polymerase a activity with aging correlates well with the decrease 
in replicative DNA synthesis taking place in aging tissue (Hubscher et^  
al., 1977; Krauss and Linn, 1982). Replicative DNA synthesis in mouse 
sarcoma cells was shown to be inhibited by aphidicolin a specific 
inhibitor of DNA polymerase a (Seki et al., 1980).
DNA polymerases £ and y may have minor roles in 'S' phase DNA 
replication. A small increase in DNA polymerase B activity has been shown 
to occur in rat liver following partial hepatectomy (Chiu et al., 1974). 
This may be associated with the ability of the enzyme to fill small gaps 
in DNA arising from the removal of RNA replication initiators (Craddock, 
1981). The involvement of DNA polymerase y in mitochondrial DNA 
replication is well established (Hubscher et_ al., 1979) but its role in 
nuclear DNA replication is unclear.
The finding that DNA polymerase £ activity remains relatively 
constant throughout the cell cycle (Wist, 1979) and during the 
replicative life-span of certain cells in, culture (Krauss and Linn, 1982) 
supports a role for DNA polymerase £ in DNA repair processes. Rossignol 
et al. (1980) have shown that protein synthesis is not required for the 
repair of low level alkylation damage, further suggesting that the 
enzyme(s) responsible for repair are constitutive. Many nuclei deficient 
in DNA polymerase a can still perform DNA repair (Bertazzoni et al., 
1976; Hubscher et a^., 1979). Most evidence for the repair roles of DNA 
polymerase £ has been obtained from the use of differential inhibitors of 
the polymerases (Seki et al., 1980; Miller and Chinault, 1982; Ramsay and 
Westerman, 1980).
Wawra and Dolejs (1979) have shown that the pattern of inhibition of 
DNA polymerase £ produced by chemical inhibitors was reflected in the 
inhibition of DNA repair. Later, isolated DNA polymerase £ was found to 
have greater activity on bromodeoxyuridine or UV-treated DNA than DNA 
polymerase a (Nowak et_ al., 1980; Siedlecki et aJL., 1980)
More recent evidence suggests that the involvement of a particular 
DNA polymerase with DNA repair processes may be determined by the size of 
the repair patch (Miller and Chinault, 1982).
1.5 THE FIDELITY OF DNA SYNTHESIS
The DNA polymerization reaction may be represented by the equation 
shown in figure 1.6a in which 5'-deoxynucleoside triphosphates 
complementary to parental DNA or template are incorporated via 
phosphodiester linkage onto the 3'-hydroxy terminus of primer DNA which 
is hydrogen-bonded to the template
Studies on human KB cell DNA polymerases a and B have shown that 
the reaction proceeds by an ordered sequential terreactant mechanism 
(figure 1.6b) (Fisher and Korn, 1981; Wang and Korn, 1982; Korn et al.,
1981).
The role of zinc in the polymerization process is not understood but 
it has been postulated that it co-ordinates to the 3'-OH primer terminus, 
facilitating deprotonation, prior to attack on the a-phosphorus atom of 
the incoming deoxynucleoside triphosphate (Mildvan and Loeb, 1979). The 
role of the divalent cation appears to be the formation of a bridge 
between enzyme and the terminal phosphoryl group of the nucleotide, 
facilitating the departure of the pyrophosphate leaving group (Sloan et 
al., 1975).
The accuracy or fidelity with which DNA polymerases copy a DNA 
template, may be measured in vitro using an assay system developed by 
Loeb and his colleagues (Springgate and Loeb, 1973; Bat tula and Loeb, 
1974). Using this system, the frequency of incorrect base selection by 
DNA polymerases during DNA synthesis may be quantified using synthetic 
polynucleotides of known base composition (usually homopolymers or 
heteropolymers). Using polydA.oligodT as template:primer for example, the
3
incorporation of the complementary nucleotide dTTP (labelled with H)
by a DNA polymerase into polymeric material was measured. The
incorporation of non-complementary nucleotides, in this case either dGTP
32or dCTP may be measured in the same assay using P-labelled dGTP or
3
dCTP, or in parallel assays in which either H-labelled dGTP or dCTP
3
replace [ H]dTTP as the radiolabelled nucleotide.The ratio of
incorporation of non-complementary nucleotides to complementary
nucleotides into polymeric material is known as the error rate.
The error rates of DNA polymerases purified from various prokaryotic
and eukaryotic sources have been measured using similar in vitro assay
-2 -6systems, and range from 10 to 10 (see table 1.3 and also section 
3.3). However, measurements of error rates in vivo are more accurate 
(Kunkel and Loeb, 1980; Fersht, 1979; Fersht and Knill-Jones, 1981) since 
the constraints of artificial templates on base selection are as yet
The DNA polymerase reaction
Primer -3 -OH
A T G C C T 
T A  C G G A G G A T
d ATP + dCTP + dGTP+dTTP
Template
Mg DNA polymerase
.. .j. r )  _ 3 - O H
A T G C C T C
T A C G G A G G A T
PPi + dATP + dGTP+ dTTP
O r d e r e d  s e q u e n t i a l  r e a c t i o n  m e c h a n i s m
Template Primer dNTP 
A 9 C
id  vk
PPi + tem plate* primer 
P+ Q + R
/IS
.E EA EAB E A B C  EPQR
DNA
polymerase
( F r o m :  F i s h e r  a n d  K o r n , 1 9 8 1  )
Table 1.3.
The fidelity of some prokaryotic and eukaryotic DNA polymerases*
Enzyme source Error rate
E.coli DNA polymerase I 1/8000
T4 DNA polymerase
DNA polymerase a
Rat liver
Human placenta
Calf thymus
HeLa cells
1/42300
1/16500
1/12000
1/4500
1/4830
Reference
Agarwal et al.(1979)
Kunkel et al.(1979)
Chan and Becker, 
(1979)
Seal et al.(1979)
Kunkel et al.(1979)
Dube et al.(1979)
DNA polymerase B 
Calf thymus 
Rat liver
Human placenta
1/11800
1/18900
1/20000
Dube et al.(1979)
Chan and Becker, 
(1979)
Seal et al.(1979)
AMV DNA polymerase 1/1400 Si rover and Loeb, 
(1977)
* Template was poly(dA-dT) and the non-complementary nucleotide was 
dGTP except in E.coli DNA polymerase I where the non-complementary 
nucleotide was dCTP.
unknown.
The universal requirement for divalent metal cations, a template 
bearing a hydrogen-bonded primer with a 3'-OH terminus and the presence 
of zinc, suggests that the mechanism of polymerization is very similar in 
all DNA polymerases. Yet the differences in error rate observed between 
DNA polymerases from different sources suggests that the polymerase 
itself exerts some selectivity during the polymerization reaction. The 
means by which DNA polymerases achieve fidelity in copying synthetic 
templates has been the subject of much investigation.
If the insertion of nucleotides into DNA was governed solely by 
Watson-Crick base-pairing, the difference in free energy between 
complementary and non-complementary base pairs, calculated to be between
1-3 kcal/mol (Mildvan, 1974) would be insufficient to account for the 
error rates observed, in vitro since one error in 10n base pairs has 
been calculated to require a free energy difference (AG) of 1.4n 
kcal/mol between complementary and non-complementary base pairs (Loeb et 
al., 1974). Watson-Crick base-pairing alone would yield error rates of 
10_1 to 10“2.
The nature of the polymerization process itself yields a mechanism by 
which high fidelity is achieved. In a sequential ordered mechanism of 
reactant addition, binding of each substrate in turn must significantly 
alter the binding site for the following substrate, such that slight 
perturbations will prevent polymerization from taking place. The length 
of primer required varies on the polymerase and metal cation (Wang and 
Korn, 1982), but all polymerases require that the 3'-OH terminus be 
base-paired to the template (Wang and Korn, 1982). Certain metal ions 
have been shown to reduce the fidelity of DNA polymerases in vitro 
(Sirover and Loeb, 1976; Miyaki et al., 1977). This is thought to be due 
to perturbation of the polymerase:primer interaction (Fisher and Korn, 
1981). Differences in fidelity between DNA polymerases from various 
sources may also be due to differences in processivity.
DNA polymerase a synthesizes DNA in long stretches; therefore after 
initially binding template:primer, insertion of nucleotides occur along a 
length of DNA before the polymerase dissociates. In contrast, DNA 
polymerase B binds to small gaps in DNA and appears to dissociate after 
the insertion of 1-2 nucleotides (Wang and Korn, 1980). This constant 
dissociation and reassociation may lead to errors.
The fidelity with which isolated DNA polymerases copy synthetic 
templates may be enhanced by the presence of certain DNA binding proteins 
(Kunkel et al., 1979). These proteins presumably act by holding the
template-.primer in a suitable conformation for polymerization.
DNA polymerases are postulated to contain only one nucleoside 
triphosphate binding site (Englund et al., 1969) thus competition between 
nucleotides must exist. Under circumstances, for example where the 
parental nucleotide in DNA has been modified such that it can now form a 
stable, though non-complementary base-pair, then the extent to which this 
event takes place depends on the relative concentration of dNTPs 
available both in vivo and in vitro (Meuth, 1981; Kunkel et al., 1982). 
There is some evidence that in vivo DNA polymerase a may be associated 
with a regulatory protein which regulates the supply of deoxynucleotides 
to the polymerase (Steinberg et al., 1979; Reddy and Pardee, 1980) thus 
acting as a kind of editing mechanism.
The observation that prokaryotic DNA polymerases have slightly lower 
error rates in vitro than DNA polymerases from mammalian sources was 
thought to be associated with the presence of a 3'—51 exonuclease 
activity within the prokaryotic enzymes (Brutlag and Kornberg, 1972). The 
exonuclease has been shown to perform a proof-reading function. Sloan et 
al. (1975) have shown that the incoming nucleotide is held in the correct 
conformation for base-pairing to take place with the complementary 
nucleotide. If a non-complementary base pair is formed, the slightly 
altered conformation stimulates exonucleolytic action by the 3'-5' 
exonuclease in which the incorrectly paired nucleotide is removed and 
repolymerization takes place. It has been found that alteration of the 
ratio of DNA polymerase activity to exonuclease activity in certain DNA 
polymerases (induced in E.coli by various strains of 'phage T^) has 
been shown to lead to increased or decreased misincorporation of 
nucleotides into synthetic templates (Hall and Lehman, 1968; Muzyczka et 
al., 1972) in vitro.
Both DNA and RNA polymerases in mammalian cells lack inherent 
exonuclease activity (Springgate and Loeb, 1973; Chang, 1973). The one 
exception is DNA polymerase 6 (section 1.4). Distinct exonuclease 
activity has been detected in mammalian cells (Hollis and Grossman, 1981) 
which may in part be responsible for the high fidelity of the DNA 
polymerization reaction observed in vivo. The presence of 3'-5' 
exonuclease activity associated with DNA polymerases may not be 
advantageous. Hopfield (19ao) has shown that prokaryotic DNA polymerases 
degrade DNA in the absence of deoxynucleotides. Fersht et al. (1982) has 
also shown that proof-reading processes during DNA polymerization use 
vast amounts of energy since substrates are turned over uselessly in the 
search for correctly matched base-pairs when correct base-pairing is not
possible.
The existence of mismatch repair processes also appears to be a 
mechanism by which the fidelity of DNA polymerization is enhanced. 
Repetitive cycles of excision of mismatched bases followed by 
repolymerization would increase the chances of the correct nucleotide 
sequence insertion (Loeb and Kunkel, 1982).
1.6 THE ROLE OF DNA POLYMERASES IN MUTAGENESIS
The fidelity of DNA polymerases must play an important role in 
mutagenesis. Following exposure of cells in vivo or in vitro to chemical 
carcinogens and mutagens, DNA damage is normally rapidly repaired. 
However in the absence of DNA repair or if DNA repair is defective, DNA 
polymerases must cope with modified templates. When a DNA polymerase 
encounters a damaged base there are three posible courses of action; DNA 
synthesis may stop at the site of damage or the DNA polymerase may 
read-over the damage and insert the correct nucleotide or 
misincorporation, according to the Watson-Crick base-pairing, may take 
place.
The effect of the presence of various alkylated bases in synthetic 
and natural DNA templates on the fidelity of purified DNA polymerases 
from bacterial and mammalian sources has been measured in vitro. One of 
the major products of attack on DNA by alkylating agents, 7-methyl 
guanine, does not miscode when present in modified templates (Ludlum, 
1970). However guanine alkylated at the 0-6 position and thymine 
alkylated at the 0-4 position, have been shown to induce mispairing in 
vitro (Gerchman and Ludlum, 1973; Abbot and Saffhill, 1977). These 
alkylated bases are formed in small quantities in DNA in vivo following 
exposure to certain SN^ type alkylating agents (Margison and O'Connor, 
1979).
Depurination of DNA is enhanced following the alkylation of purines 
at N-7 and N-3 (Lawley and Brookes, 1963). Depurination of synthetic 
templates resulted in miscoding, when copied by avian myeloblastosis 
virus (AMV) DNA polymerase which, lacks a 3'-5' exonuclease activity 
(Shearman and Loeb, 1977). Similarly depurinated <j>Xl74 DNA has also 
been shown to induce miscoding by E.coli DNA polymerases (Schaaper and 
Loeb, 1981).
Miscoding by isolated DNA polymerases has been shown to occur on 
synthetic templates treated with B-propiolactone (Sirover and Loeb, 1974) 
and vinyl chloride metabolites (Hall et al., 1981; Barbin et al., 1981). 
There is also some recent evidence to show that miscoding can occur 
following treatment of synthetic templates with certain intercalating 
agents (Sirover and Loeb, 1980).
Nucleophilic centres in proteins are also susceptible to attack by 
chemical carcinogens and mutagens. Such modification of DNA polymerases 
and accessory proteins required in the DNA polymerization reaction may
result in altered fidelity of DNA synthesis. This aspect has been
discussed in detail in sections 4.3 and 5.3.
Mutagenesis has been postulated to be intimately involved with 
processes such as cancer and aging. The involvement of DNA polymerases in 
these processes remains unclear but there are several lines of evidence 
which show a reduction in DNA polymerase fidelity associated with these 
conditions. Springgate and Loeb (1973) found that leukaemic cell extracts 
copied synthetic polynucleotides with much lower fidelity than extracts 
from normal lymphocytes. However the decrease in fidelity has not yet 
been shown to be due to an altered DNA polymerase. Later, the possible 
viral origins of cancer (Temin, 1974) lead Mizutani and Temin (1976) to 
analyse the fidelity of several viral-encoded DNA polymerases using 
synthetic templates. The viral reverse-transcriptases copied synthetic 
DNA with very low fidelity when compared to E.coli DNA polymerase I.
Much more evidence implicates the involvement of low fidelity DNA 
polymerases in the aging process. The theory of cellular aging, proposed 
by Orgel (1973) suggests that errors in protein synthesis accumulate 
leading to an accumulation of errors in DNA. The progressive loss of 
information transfer thereby affects a wide range of cellular components 
and processes. The appearence of a low fidelity DNA polymerase prior to 
aging or during this process would introduce a high frequency of genetic 
errors.
A progressive loss in DNA polymerase fidelity with increasing passage 
number has been found in human fibroblasts (Linn et al., 1976). The
altered fidelity appears to be due to modification of the normal DNA 
polymerase a since no new polymerase was detected (Murray and Holliday, 
1981). More recently, Krauss and Linn (1982) have shown that DNA 
polymerases a, B and y from aged HeLa cells and I MR-90 human diploid 
fibroblasts all show decreased fidelity when compared to early passage 
enzymes.
The existence of error-prone DNA polymerases which appear during the 
so-called 'SOS' response in bacteria and mammalian cells are a means by 
which the cell can survive the cytotoxic effects of many genotoxic 
agents. Error-prone DNA polymerases can copy DNA regions containing 
damage which under normal circumstances would block DNA synthesis past 
the damaged site. DNA polymerases which have been induced following 
exposure to chemical carcinogens have been isolated from cultured rat 
fibroblasts and HeLa cells (Bozhkov et al., 1978; Noy and Weissbach,
1977). The rat enzyme has been shown to have reduced fidelity on 
7-bromomethylbenzanthracene-modified polydA.oligodT, compared to enzymes 
isolated from untreated cells. DNA polymerases induced during the 'SOS'
response are also error-prone on normal DNA templates (Das Gupta and
Summers, 1978).
Topal and Fresco (1976) have shown that several base-pairing
structures can be formed without excessive distortion of the DNA helix by
non-complementary bases. The result of the presence of various altered 
bases in DNA has been shown to result in ambiguity rather than a
cessation of synthesis by isolated RNA polymerases (Singer and Spengler, 
1981; Kroger and Singer, 1979). Similar ambiguities may occur during DNA 
synthesis by error-prone or even normal DNA polymerases.
There is some evidence that slight changes in the amino acid sequence 
may alter the discriminatory properties of DNA polymerases. Studies on 
the incorporation of adenine or 2-amino purine into partially digested 
DNA by DNA polymerases from wild type and mutant Salmonella typhimurium 
strains have shown that the wild-type enzymes are able to discriminate 
more effectively against 2-amino purine despite the fact that it is an 
analogue to adenine and has similar base-pairing properties (Engler and 
Bessman, 1978). It is not yet known whether new error-prone activities 
observed in mammalian cells are due to new gene products or due to 
modification of a normal DNA polymerase activity. Radman et al. (1978 and 
1977) have suggested that the decreased fidelity of DNA replication 
observed in vivo during the 'SOS' response may be due to inhibition or 
alteration of exonuclease activity or DNA binding proteins. The ability 
of purified mammalian DNA polymerases a and B to copy past pyrimidine 
dimers in vitro supports this view but does not explain the requirement 
for protein synthesis which precedes the appearance of the error-prone 
response.
1.7 AIMS OF THE PRESENT STUDY
The aims of the research project undertaken at Surrey University
between October 1979 and September 1982 were:
1. To develop an assay system in which the fidelity of DNA polymerases 
associated with DNA repair processes could be measured.
2. To study the effect of various genotoxic compounds on the fidelity of 
DNA polymerases in vitro.
3. To study the effect of in vivo administration of certain genotoxic
chemicals on the amount of DNA polymerase B activity in rat liver
nuclei and to assess the effect of such treatment on the fidelity of 
DNA polymerase activity.
CHAPTER 2
DEVELOPMENT OF AN IN VITRO ASSAY SYSTEM FOR THE MEASUREMENT 
OF ACTIVITY AND FIDELITY OF DNA POLYMERASES
2.1 INTRODUCTION
The simplest system for the measurement of DNA synthesis in vitro 
consists of an activated DNA or synthetic polynucleotide of known base 
composition: a mixture of deoxynucleotides, usually dATP, dGTP, dCTP and 
dTTP (one of which is radiolabelled): a DNA polymerase, magnesium ions 
and possibly a thiol protecting agent (table 2.1). The extent of 
incorporation of the radioactive nucleotide into polymeric material gives 
a measure of the extent of DNA synthesis. Many assay systems of this type 
have already been reported (Chang, 1973; Dube et al., 1979; Agarwal et 
al., 1979; Sirover and Loeb, 1976).
The accuracy or fidelity with which a DNA polymerase copies a DNA 
molecule of defined base composition can be determined by measuring the 
ratio of incorporation of a radiolabelled non-complementary 
deoxynucleotide, (that is, one which does not form a normal Watson-Crick 
base pair), and a radiolabelled complementary deoxynucleotide, into 
polymeric material. This ratio has been termed the error rate or error 
frequency of the DNA polymerase. Thus:
Error frequency = pmol of non-complementary deoxynucleotides inserted
pmol of complementary deoxynucleotides inserted.
Measurements of the fidelity of isolated DNA polymerases can vary 
from approximately 1/100 to 1/100000 errors (see chapter 1). The average 
complementary nucleotide insertion (dTTP) into poiydA.oligodT-^^g (a 
homopolymer containing around 2000 deoxyadenosine monophosphate moieties 
base paired with a short primer of 12-18 thymidine monophosphate moieties 
at one end), achieved by the assay system to be described is in excess of
o  1 3
200pmol per h at 37°C. This corresponds to insertion of about 10
-3 -4
complementary bases. To achieve error frequencies of 10 or 10
9 -2would require misincorporation of 10 bases corresponding to 10 to
-3
10 pmol. Thus, to obtain an accurate determination of error frequency 
it is necessary to use non-complementary nucleotides of specific activity 
in excess of 1000 d.p.m./pmol, rendering measurement accessible in modern 
scintillation counting equipment, (Table 2.2).
The aim of work described in this chapter was to set up reproducible 
assay systems for the measurement of DNA synthesis and fidelity, by DNA 
polymerases from various sources. The enzymes used were Escherischia coli 
DNA polymerase I, Micrococcus luteus DNA polymerase, and calf thymus DNA 
polymerase a.
Table 2.1
General requirements for DNA polymerization by DNA polymerases in vitro
2+ 2+
Mg or Mn 2-10mM
+■ +
K or Na lOOmM
sulphydryl reagent 10mM
(2-mercaptoethanol or dithiothreitol) 
dATP 10yM
dGTP 10uM
dCTP 10yM
dTTP 10yM
nicked/gapped DNA or synthetic polynucleotide
Table 2.2
Limits of Detection of Misincorporation.
Non-complement a ry
3
[ H]dNTP
specific activity 
(d.p.m./pmol)
Theoretical
detection
limit
(pmol)
Measurement at 
limit of 
detection 
(c.p.m.)*
100
1000
10000
100000
1.0
0.1
0.01
0.001
40
40
40
40
[ H] counting efficiency of 40%
2.2 MATERIALS AND METHODS
2.2.1 Materials
Calf thymus DNA (highly polymerized type); bovine serum albumin
(fraction V); deoxyribonuclease I (bovine pancreas); dGTP, dATP, dCTP and
dTTP (sodium salts) were all purchased from Sigma . [H]-labelled dNTPs
3
(10-50 Ci/mmole) and n-[ H]-hexadecane were from Amersham. M. luteus 
DNA polymerase; calf thymus DNA polymerase a and polydA.oligodT12_18 
were from PL biochemicals. E.coli DNA polymerase I was from Boehringer; 
polydeoxyadenylate was from Miles; GF/C and DE 81 2.5cm filter discs were 
from Whatman and polyethylene-imine cellulose F plastic coated t.l.c. 
plates were from Merck. Scintillation cocktail, NE 260 was purchased from 
Nuclear Enterprises Ltd.
2.2.2 Activation of DNA
DNA was activated using a modification of the method of Aposhian and 
Kornberg (1962).
Calf thymus DNA (5mg) in 2.0ml 50mM Tris-HCl buffer, pH 7.5
containing 5mM MgCl~ and 1.25mg/ml BSA was treated with 0.5ml
-3
deoxyribonuclease I (12.5 x 10 yg/ml in 50mM Tris-HCl, pH 7.5). 
Incubation was for 15min at 37°C. DNAase I in samples was inactivated 
by incubation at 77°C for 5min. Samples were cooled on ice and stored 
at -20°C.
The increase in absorbance at 260nm, due to release of 
deoxyribonucleotides during the 15rain incubation period, was measured on 
a Varian Cary 219 spectrophotometer, and was found to be 0.003 A260 
units/min at 37°C.
2.2.3 Measurement of DNA synthesis by calf-thymus DNA polymerase a.
DNA synthesis by the enzyme was determined by measurement of the
3
incorporation of [ H]dTTP into polymeric material. The reaction mixture 
in 12mm x 75mm borosilicate culture tubes contained: lOOyM each of
3
dATP, dGTP, dCTP and [ H]dTTP (15c.p.m./pmol); 40mM potassium phosphate 
buffer pH 7.2; 8mM MgCl2; 2mM 2-mercaptoethanol; 0.02mM polydA.oligodT 
(in lOmM NaCl containing O.lmM EDTA) or 50yg of activated DNA. The 
total volume was made up to lOOyl by the addition of distilled water.
The reaction was initiated by addition of calf thymus DNA polymerase
•k
a (2 units in 25yl of 50mM Tris-HCl buffer pH 7.5, containing 20% 
(v/v) glycerol and lmg/ml BSA) and samples were incubated at 37°C in 
a shaking water bath. Blanks contained distilled water in place of 
template. The reaction was stopped by placing tubes on ice. The
3
incorporation of [ H]dTTP into polymeric material was determined by 
liquid scintillation counting after isolation of the polynucleotide as 
described in section 2.2.6.
* One unit catalyzes the incorporation of Inmole of dATP into an 
acid-precipitable product with poly(dT).f(A)12_lg as the 
template:primer in lh at 37°C.
2.2.4 Measurement of DNA synthesis by M.luteus DNA polymerase
DNA synthesis was determined by the measurement of the level of
3
incorporation of [ H]dTTP into polymeric material. The reaction mixture 
contained: 50yM each of dATP, dGTP, dCTP and [3H]dTTP
(15d.p.m./pmol); lOOrnM Tris-HCl pH 8.0 (containing 5mM
2-mercaptoethanol); 4mM MgCl2 and 55yg activated DNA or lyg of 
polydA.oligodT (in 0.01M Tris-HCl buffer pH 7.0 containing lOOmM NaCl).
•k
The reaction was initiated by addition of 0.1 units of M. luteus 
DNA polymerase in lOyl of 50mM Tris-HCl buffer pH 7.5, containing 20% 
(v/v) glycerol, lOmM 2-mercaptoethanol, and lmg/ml BSA (enzyme buffer). 
The final incubation volume was 200yl. The tubes were incubated at 
37°C in a shaking water bath. The reaction was stopped by placing the 
tubes on ice and the radioactivity incorporated into polymeric material 
was measured as described in section 2.2.6.
* One unit catalyzes the incorporation of lOnmole total nucleotide into 
acid-insoluble product at 37°C in 30min.
2.2.5 Measurement of DNA synthesis by E.coli DNA polymerase I
The reaction mixture (in a total volume of 250yl) contained 80yM
3
each of dATP, dGTP, dCTP and [ H]dTTP (35 d.p.m./pmol); 60mM KC1; 50mM 
Tris-HCl buffer, pH 7.5; 5mM MgCl2; 2.4mM 2-mercaptoethanol and 0.02411114 
polydA.oligodT (in 0.01M Tris-HCl pH 7.0 containing lOOmM NaCl - template 
buffer).
The reaction was initiated by the addition of 0.1 units (see 
section 2.2.4.) of E.coli DNA polymerase I (in 25yl of enzyme buffer). 
The tubes were incubated at 37°C and the reaction was stopped after 
the appropriate time by placing tubes on ice. Radioactivity incorporated 
into polymeric material was measured as described in section (2.2.6).
2.2.6 Isolation of newly synthesized radiolabelled polynucleotide
3
DNA or synthetic polynucleotide labelled with [ H] in vitro during 
DNA synthesis by DNA polymerases was isolated after the reaction had been 
stopped by one of the following methods.Modifications of these methods 
are described in section 2.3.
(a) Perchloric acid (PCA) precipitation (Dube et al., 1978).
To the reaction mixture was added 2.0ml cold 0.1M PCA containing
0.05M sodium pyrophosphate, followed by 1ml carrier DNA (calf thymus DNA, 
lmg/ml in distilled water). After vortexing, the mixture was filtered 
through a GF/C disc and washed repeatedly with 1.0M PCA. Finally, each 
disc was washed with ethanol and allowed to dry in air. The amount of
3
[ H] retained on discs was determined by liquid scintillation counting 
(section 2.2.8).
(b) DE 81 ion-exchange chromatography (Lindell et a^., 1970).
Aliquots (lOOyl) of reaction mixture were placed onto DE 81 
cellulose discs. After the liquid had soaked in, discs were batch-washed 
in 5% (w/v) Na^HPO^ (5-10ml/disc) for approximately 4min. The liquid 
was decanted off and the discs were washed a further four times in 5% 
(w/v) Na^HPO^. The discs were then washed twice with distilled water, 
twice in 96% (v/v) ethanol and finally twice in diethyl ether. After 
drying in air, radioactivity retained on the disc was measured by liquid 
scintillation counting.
(c) TCA precipitation of DNA (Bollum, 1966).
The reaction mixture was applied to GF/C filter discs.After the 
liquid had soaked in, discs were placed in ice-cold TCA (5% w/v) 
containing 1% (w/v) Ua^P^O^, (lOml/disc). After lOmin the liquid
was decanted off and replaced with 5% (w/v) TCA. After a further wash in 
5% (w/v) TCA, the discs were washed twice in 95% (v/v) ethanol and
finally twice in diethyl ether. After drying in air, the radioactivity 
retained on the discs was measured as described in section 2.2.8.
2.2.7 Fidelity Assay. (Measurement of the incorporation of 
non-complementary deoxynucleotide triphosphates into synthetic 
DNA template of known composition by DNA polymerases)
3
The incorporation of [ H]dTTP into polydA.oligodT was determined as 
described in sections 2.2.3 and 2.2.5. In concurrent experiments
3
[ H]dTTP was replaced as the radioactive dNTP in the reaction mixture
3
by one of the following non-complementary nucleotides: [ H]dATP,
3 3
[ H]dGTP, or [ H]dCTP at a specific activity of approximately
5000d.p.m./pmol.
3Solvent was removed from the non-complementary [ H]dNTP's (as
supplied) by evaporation in a gentle stream of nitrogen. The temperature
of the solution did not exceed 30°C during the process which normally
took l-2min. Following removal of solvent, reaction mixture (as described
3in section 2.2.3 or 2.2.5) minus [ H]dTTP was added. The concentration
of the 'cold' non-complementary nucleotide used was adjusted to yield a
specific activity of 5000d.p.m./pmol. The reaction was initiated by 
addition of enzyme solution and reaction conditions and isolation of 
labelled polymeric material were identical to those described for the
3
measurement of [ H]dTTP incorporation into polydA.oligodT or activated 
DNA.
2.2.8 Liquid scintillation counting
3
Discs containing [ H]-labelled polynucleotide were placed in 20ml 
polyethylene scintillation vials (Koch-Light) containing 7ml of 
scintillation cocktail (NE 260), and counted using an external standard 
in an LKB Ultrobeta, model 1216 liquid scintillation counter. The
3
counting efficiency for [ H] was determined as 40% using
3
n-[ H]-hexadecane as internal standard.
3
2.2.9 Purity of [ H]-labelled deoxynucleoside triphosphates
3
The purity of [ H]-labelled deoxynucleoside triphosphates (dNTP's) 
used in the fidelity assays was assessed by thin-layer chromatography on 
polyethylene-imine cellulose F plates using 2M lithium chloride and 2M 
formic acid (1:1) as the solvent system (Randerath and Randerath, 1964). 
Samples (20yl) of ImM dNTP (in H^O) containing O.lyCi of [^H]dNTP 
were applied to the plates.
The position of the nucleotides was visualized under UV light (254nm; 
Mineralite, California). More permanent visualization was achieved by 
treating plates with freshly prepared nucleotide reagent (Thomson, 1969):
Ammonium molybdate (lg/8ml I^O) ( 8 vol)
Hydrochloric acid (12M) ( 3 vol)
Perchloric acid (60%) ( 3 vol)
Acetone (86 vol)
After quickly immersing t.l.c. plates in reagent, the plates were 
dried in air, exposed to UV light for at least 30min and exposed to 
ammonia fumes, yielding blue spots at the position of nucleotides. The 
position of radioactivity was located using a Berthold t.l.c. scanner.
2.3 RESULTS AMD DISCUSSION
DNA synthesis by M.luteus DNA polymerase.
The enzyme DNA polymerase from M.luteus was chosen initially to
develop an in vitro assay system for DNA synthesis as it was obtainable
commercially and a literature method for measurement of DNA synthesis was
available for this enzyme (Harwood et al., 1970). Incorporation of
3
[ H]dTTP into activated DNA by the enzyme was almost linear for at
3
least 4Qmln (figure 2.1). Incorporation of [ H]dTTP into polydA.oligodT 
appeared to have a lag period over the initial 20min where incorporation 
was slow relative to the subsequent 20min period. This is characteristic
3
of an autocatalytic reaction. Incorporation of [ H]dTTP into polymeric
material in the absence of enzyme or template was less than 1% of the
total incorporation thereby providing suitable controls for the reaction
(Table 2.3). Magnesium ions are postulated to be essential for
2+polymerization (Mildvan and Loeb, 1979). Replacement of Mg with other 
divalent cations have been shown to alter the rate of incorporation of 
complementary nucleotides into polymeric material during DNA synthesis 
(Sirover and Loeb, 1976). In the present study, incorporation of
3
[ H]dTTP into both activated DNA and polydA.oligodT in the absence of
MgC^ was about 15% of that observed in the presence of ^gCl^. This
extent of incorporation may have been due to the presence of metal ion
2+impurities in the enzyme and DNA samples, or due to Mg present in the
distilled water used for the preparation of the substrate solutions.
24-
Consequent ly, elimination of Mg from the reaction buffer did not 
provide an adequate control for the DNA polymerization reaction.
Isolation of newly synthesized radiolabelled polynucleotides from 
reaction mixtures.
Adequate removal of non-incorporated deoxynucleotides from DNA or 
synthetic polynucleotides was necessary for accurate measurements of
3
[ HjdTTP incorporation into DNA or synthetic polynucleotides and the 
fidelity of DNA polymerases, since high blank values may have led to 
miscalculation of levels of activity and fidelity. Three methods for the 
isolation of newly synthesized polymeric material were tested which 
involved sampling of the DNA polymerase reaction mixture onto filter 
discs and elution of radioactivity not incorporated into polymeric
material by various solvent systems:
oujd)
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Table 2.3.
2 +Effect of absence of template, enzyme or Mg on DNA.
M.luteus DNA polymerase
Radioactivity Incorporated 
(c.p.m./h)
Complete system 7123
Complete system 24
at 0°C
Without enzyme 25
Without template 48
Without Mg^+ 1137
synthesis by
% of maximum 
incorporation
100
0.34
0.35
0.67
15.96
3
[ H]dTTP incorporation into polymeric material was measured as 
described in section 2.2.3. Control incubations were performed by 
replacement of enzyme, template or MgClj with distilled water.
1. Precipitation of DNA by PCA/Na^P^O^ onto GF/C filter discs and
subsequent elution of non-reacted deoxynucleotides by washing with
PCA,
2. Precipitation of DNA by TCA/Na^P^O^ onto GF/C filter discs and
subsequent elution of non-reacted deoxynucleotides by washing with
TCA,
3. Binding of DNA to DE 81 cellulose discs.
Determination of the optimum volume for GF/C disc washing to remove 
non-incorporated radioactivity following precipitation of newly
3
synthesized [ H]-labelled DNA by perchloric acid.
Stopping solution, PCA/Na^P^O^ was added to duplicate, time
zero reaction mixtures for M.luteus DNA polymerase, followed by 1ml of 
carrier DNA as described in section (2.2.6). Each sample was then applied 
to a GF/C filter and the radioactivity in a lOOyl aliquot of filtrate 
was measured by liquid scintillation counting. Each filter disc was
subsequently washed with 40 x 1 ml samples of PCA/Na^P^ and
radioactivity in lOOyl of filtrate from each wash was determined.
Radioactivity remaining on the disc was measured after applying 30 and 40 
ml of washing solution. The procedure was repeated using enzyme solution 
which did not contain bovine serum albumin.
After washing with 30ml, the radioactivity remaining on the disc was 
approximately 36 c.p.m., accounting for approximately 0.04% of the total 
radioactivity initially applied to the disc (figure 2.2). This count was 
reduced to 9 c.p.m. by washing with a further 10ml. These values did not 
change significantly in the absence of BSA in the reaction mixture.
3
Removal of non-incorporated [ Hj-labelled deoxynucleotides from DE 81 
cellulose.
The cellulose matrix and positively charged groups of 
diethylaminoethyl cellulose (DEAE-cellulose) are responsible for binding 
of DNA to DE 81 discs. Since ion exchange is involved, the extent of 
binding of DNA and deoxynucleotides depends upon the ionic strength and 
pH of the eluting solution. By variation of these parameters it was 
possible to remove selectively, non-incorporated deoxynucleotides from 
the DE 81 disc.
Several eluting solutions of varying pH and molarity were tested for 
their ability to remove non-incorporated radioactivity from DE 81 discs
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as follows: Ice-cold, lOOyl aliquots of complete DNA polymerase
3
reaction mixture (time zero) containing 4yCi of a [ H]dNTP were 
applied to DE 81 discs. Each disc was washed in the appropriate test 
solution (10ml per disc) for a maximum of 4min. After this time the 
liquid was decanted off and discs were then washed twice in distilled 
f^O, twice in ethanol (96%, v/v) and twice in diethyl ether. After the 
final wash the discs were air-dried and radioactivity remaining bound to 
the disc was measured as described in section (2.2.8). The percentage of 
the total applied radioactivity remaining on the disc after this 
procedure is shown in table 2.4.
The extent of the removal of the radioactivity increases with 
increasing molarity and pH. Sodium phosphate (Na^HPO^, 0.7M) or 0.3M 
sodium phosphate solution, pH 10, removed the greatest amount of 
radioactivity after a single wash. Removal of purine deoxynucleotides and 
pyrimidine nucleotides was not significantly different (at the 5% level).
It was necessary to ensure that the washing solution removed only
3
non-incorporated radioactivity and not [ H]-labelled DNA. To verify 
this, duplicate reaction mixtures were set up as described in section 
2.2.3. After incubation for 60min. the reaction was stopped by placing 
tubes on ice and lOOpl aliquots were sampled from each tube onto DE 81 
discs. One group of duplicates was washed with 0.35M Ha^HPO^, pH 8.8, 
the second group with 0.3M Na^HPO^/NaOH, pH 10. Results are shown in 
table 2.5.
3The higher apparent incorporation of [ HjdTTP into polymeric 
material in 60min, obtained using the former solution was not due to 
inadequate removal of non-incorporated radioactivity, since control 
values obtained using both solutions were almost identical. Instead, it 
seems highly likely that the latter washing method removed some of the 
newly synthesized polynucleotide from the DE 81 disc.
Comparison of methods for isolation of newly synthesized 
DNA or polynucleotide after in vitro synthesis.
In vitro assays for DNA synthesis by M.luteus DNA polymerase using
activated DNA were set up as described in section 2.2.4. At various time 
3
intervals, [ H]dTTP incorporation into polymeric material was measured 
after isolation of DNA using each of the methods described previously 
(section 2.2.6). The results (shown in figure 2.3.) are the mean of 2 
determinations.
Table 2.4.
Effect of molarity and pH of disc washing solutions on the retention
3of non-incorporated [ Hl-deoxynucleotides on DE 81 cellulose discs
Radioactivity retained on DE 81 disc 
(% of total activity applied to disc)* 
Washing solution [3H]dATP [3H]dTTP [3H]dGTP [3H]dCTP
0.35M Na2HP04 0.062 0.064 0.064 0.065
(pH 8.8)
0.7M Na2HP04 0.048 0.047 0.054 0.047
(pH 9.0)
0.3M Na2HP04/ 0.200 0.180 0.250 0.190
NaH2P04 (pH 6.0)
0.3M Na2HP04/ 0.074 0.075 0.080 0.076
NaH2P04 (pH 8.0)
0.3M Na2HP04 0.043 0.040 0.047 0.045
(pH 10.0)
* Total radioactivity applied to each disc was 4yCi 
6
Table 2.5.
Effect of washing solution on the removal of non-incorporated 
radioactivity from DE 81 discs
Washing solution
[ HjdTTP incorporated net
into polydA.oliqodT. incorporation 
(c.p.m.) (pmol)
Test Control
0.35M Na2HP04 
(pH 8.8)
1360 25 239
0.3M Na2HP04 
(pH 10.0)
701 29 123
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Amounts of radioactivity retained on GF/C discs, using the PCA 
washing method, at each time interval were in good agreement with those 
obtained using the DE 81 method. Precipitation of newly-synthesized DNA 
by TCA onto GF/C discs and subsequent treatment of discs with TCA lead to 
extensive deterioration of discs, rendering them unsuitable for 
scintillation counting.
The isolation of newly-synthesized DNA on DE 81 discs has several 
advantages over the PCA method. Firstly, large numbers of samples can be 
handled using a batch washing technique without increasing the 
manipulation time, whereas the latter method involves individual 
treatment of samples. Secondly, blank values obtained using the former 
technique are consistent; spurious blank values may arise in the PCA 
method due to incomplete precipitation of DNA or polynucleotide. Dube et 
al. (1978) have reported that the presence of protein in reaction 
mixtures in excess of 25yg produces clogging of GF/C discs which may 
lead to inefficient removal of non-incorporated radioactivity. This 
effect may be important when using samples of differing protein content. 
However, protein concentration in excess of 200pg applied to DE 81 
discs did not lead to retention of non-incorporated deoxynucleotides (see 
appendix). Also, elution of non-incorporated radioactivity from GF/C 
filter discs by perchloric acid did not differ in the presence or absence 
of bovine serum albumin. A disadvantage of the DE 81 method is the 
deterioration of the discs during prolonged washing, (Ives ejt a^., 1969). 
Thus manipulation time was kept to a rna^mumof 20min.
3
Incorporation of [ H]dTTP into polydA.oligodT by
calf thymus DNA polymerase a and E.coli DNA polymerase I
Using calf thymus DNA polymerase a and E.coli DNA polymerase I, the
3
incorporation of [ H]dTTP into polydA.oligodT (measured using the assay
3
systems described in this chapter and the isolation of [ H]-labelled 
polynucleotide as described in section 2.2.6(b)) was linear for at least
3
30min. (figure 2.4). Maximal incorporation of [ H]dTTP occurred after 
90min. for both enzymes. Saturation at this stage was probably due to the 
thermal denaturation of the enzymes (see figure 4.5).
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Fidelity of polynucleotide synthesis by calf-thymus DNA
polymerase a and E.coli DMA polymerase I on polydA.oligodT
3
The amount of incorporation of [ H]dTTP into polydA.oligodT was
3 3measured in parallel with assays measuring [ H]dGTP, [ H]dCTP and
3
[ H]dATP incorporation. Ethanol solvent (required for storage stability
3
of [ H]dNTPs) was removed from non-complementary nucleotides used in 
the fidelity assays since:
a) The presence of ethanol at concentrations in excess of 2% in the
total reaction mixture dramatically reduced the level of polynucleotide 
synthesis by calf thymus DNA polymerase a, when compared to control 
experiments performed in the absence of ethanol (figure 2.5).
b) Ethanol causes depurination of DNA or synthetic polynucleotides,
when present at low concentrations (Dube et al., 1979). Depurination of
template has been shown to induce miscoding by certain DNA polymerases
(Shearman and Loeb, 1979), thus leading to high background error rates in 
control systems.
The radioactive purity of non-complementary nucleotides was routinely 
determined by thin-layer chromatography and radiochromatogram scanning. 
Deoxycytidine triphosphate is particularly unstable at 37°C, 
undergoing deamination to deoxyuridine triphosphate, (Fersht, 1981), 
which is as readily incorporated opposite deoxyadenosine in DNA as is 
dTTP by most DNA polymerases, (Dube et al., 1979). This problem is
overcome in vivo by two enzymes: uracil DNA glycosylase, which removes 
uracil from DNA (Lindahl, 1974); and dUTPase, which hydrolyses dUTP to 
dUDP and inorganic phosphate, (Fersht et al., 1982). Thus, parallel
fidelity assays must be performed using the same dCTP sample to avoid 
high background error rates due to the presence of contaminating dUTP. No 
radioactive impurities were detected as determined using the method 
described in section 2.2.9.(see appendix).
The error frequencies obtained for calf thymus DNA polymerase a and 
E.coli DNA polymerase I copying polydA.oligodT are shown in Table 2.6.
In order to verify that the radioactivity retained on DE 81 discs was
3
due to incorporation of [ H]dNTPs into polymeric material, reaction 
mixtures were treated with bovine pancreas DNAase I (table 2.7). This 
treatment resulted in the degradation of newly-synthesized polynucleotide 
as judged by the decrease in radioactivity of the isolated polymeric 
material.
The error rates observed here are in relatively good agreement with 
some values quoted in the literature (see chapter 1). However, the high
Legend to figure 2.5.
I n c r e a s i n g  v o l u m e s  o f  e t h a n o l  w e r e  a d d e d  t o  t h e  r e a c t i o n  
m i x t u r e '  ( r e p l a c i n g  d i s t i l l e d  w a t e r ) ,  i n  t h e  c a l f  t h y m u s  
DNA p o l y m e r a s e  0 4 . a s s a y .  The t o t a l  v o l u m e  was made up t o  
25 0 j u l  w i t h  d i s t i  1 l e d  w a t e r .  R e a c t i o n  m i x t u r e s  w e r e  i n c u b -  
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Table 2.7.
Effect of deoxyribonuclease I treatment on the amount of radioactivity 
incorporated into polydA.oligodT. by E.coli DNA polymerase I
[ HjdNTP in reaction 
mixture*
Radioactivity incorporated 
into polymeric material 
(c.p.m.)
-DNAase I +DNAase I
dTTP 10584 456
dGTP N.D. N.D,
dCTP 175 N.D
dATP 9804 3843
* [^H]dTTP specific activity =35.52 d.p.m./pmol
[^H]dATP, dGTP, dCTP specific activities = 5000 d.p.m./pmol
N.D. = none detectable
Parallel assays for the measurement of polynucleotide synthesis by 
E.coli DNA polymerase I were set up as described in section 2.2.5. in
3
the presence of one [ H]-labelled dNTP. After 60min, DNAase I was 
added to the reaction mixture (see section 3.2.) and incubation was 
continued for a further 15min. After this time aliquots (100yl) were
3
sampled onto DE 81 discs and [ H]dNTP incorporation into polydA. 
oligodT. was measured.
3
incorporation of [ H]dATP into polydA.oligodT by both enzymes is not
understood. This is not due to terminal deoxynucleotidyl transferase-like
3 3activity since no incorporation of [ H]dTTP or [ H]dATP was observed 
when polydeoxyadenylate was used as template in place of polydA.oligodT
3
(table 2.8). It was not possible to determine if [ H]dATP incorporation
was the result of primer copying in these studies.
The variation in error frequencies measured for these enzymes in
vitro can be explained by several factors. It is well known that
homopolymers are copied less accurately in vitro than heteropolymers
which are in turn copied less accurately than native DNA. Increased
accuracy is associated with increasing complexity of the template and is
probably associated with contraints mediated by nearest neighbours
(base-stacking) and structural features of the template, (Loeb et al.,
1978). Also, non-complementary nucleotides are more readily inserted into
homo- and heteropolymers as they may occupy looped-out structures, that
is, non-base-paired regions (Chang, 1973). DNA polymerases are postulated
to have a single dNTP binding site, (Englund, 1969); thus competition
between nucleotides for this site will depend on the ratio of
deoxynucleoside phosphates in the reaction mixture, thus affecting the
fidelity, (Meuth, 1981). Therefore, comparisons of fidelity of different
DNA polymerases are only meaningful when measurements are made using
identical templates and equal concentrations of substrate dNTPs.
In summary, assay methods for DNA polymerase a from calf thymus,
M.luteus DNA polymerase and E.coli DNA polymerase I were described in
3which newly-synthesised [ H]-labelled polymeric material was isolated 
on DE 81 cellulose filters. Batch washing of filters in 0.35M 
Na^HPO^, pH 8.8, ensured that the radioactivity retained on the disc 
was due to [^H]dNTP incorporation into DNA or synthetic polynucleotide, 
and not due to non-specific binding of non-incorporated radioactivity. In 
assays to determine the fidelity of these enzymes, it was necessary to 
remove all traces of ethanol from the reaction mixture. Under these
_3
conditions, misincorporation of dCTP, dGTP and dATP was 2.9x10 ,
-3 -33.9x10 and 6.8x10 respectively for calf thymus DNA polymerase
a. No errors were detectable for the incorporation of dGTP into
polydA.oligodT by E.coli DNA polymerase I. The error rates of this enzyme
-3 -3using the same template were 6.6x10 and 1.5x10 for dCTP and dATP 
incorporation respectively.
Table 2.8.
[^H]dTTP and [^H]dATP incorporation Into polydA.oligodT 
and polydeoxyadenylate
3
[ HjdNTP* Template Mean c.p.m. incorporated
into polymeric material.
Test Control**
dTTP polydA.oligodT 13904 37
dTTP polydA 18 16
dATP polydA oligodT 1383 644
dATP polydA 144 144
* [^H]dTTP specific activity = 35.52 d.p.m./pmol 
[^H]dATP specific activity = 5000 d.p.m./pmol
** Control incubations contained distilled H^O in place of template
CHAPTER 3
ISOLATION AND CHARACTERISATION OF DNA POLYMERIZING ACTIVITY IN 
NUCLEAR EXTRACTS FROM NORMAL AND REGENERATING RAT LIVER NUCLEI.
3.1 INTRODUCTION
Fidelity measurements of purified DNA polymerases in vitro may not 
reflect their true accuracy in vivo, since the purification process may 
result in a progressive loss of factors required for enhancement of base 
selection fidelity, through each stage in the purification procedure 
(Kunkel et al., 1979). The use of cell-free systems or nuclear extracts 
containing crude preparations of DNA polymerase may overcome this problem 
since it is highly likely that other proteins, which affect the activity 
of DNA polymerases are still present in this type of system (Danse et 
al., 1981; Kaftory and Fry, 1978; Lamothe et al., 1981). Since DNA
synthesis takes place exclusively in nuclei, (with the exception of 
mitochondria and chloroplasts), the use of a nuclear extract with low DNA 
polymerizing activity on endogenous template would be an ideal system for 
the study of the fidelity of DNA polymerases. Some success has already 
been achieved using native chromatin as a source of DNA polymerizing 
activity (Fry et a_l., 1980; Kaftory and Fry, 1978).
Normal eukaryotic cells are postulated to contain at least three 
types of DNA polymerase, the roles of which have already been reviewed 
(see chapter 1.4). The involvement of DNA polymerases a and 8 in 
nuclear DNA replication and repair, would imply a nuclear location for 
these enzymes. Yet some researchers have reported their presence in the 
cytoplasm (Haines et al., 1972; Chang and Bollum, 1972). The explanation 
for this phenomenon is that during isolation of DNA polymerases, 
homogenization of tissues in buffers containing high concentrations of 
inorganic ions (Roodyn, 1972) can lead to 'leaching' of DNA polymerase 
activity from nuclei (Craddock, 1981). Thus precautions must be taken in 
the preparation of nuclear extracts for fidelity studies, to prevent such 
loss. The most suitable method for this purpose was that of Lynch et al. 
(1975).
In the following chapter, a method is described for the preparation 
of DNA polymerase-containing nuclear extracts, which are essentially free 
of cytoplasmic contamination. The nature of the polymerizing activity in 
extracts was also characterized.
3.2 MATERIALS AND METHODS
3.2.1 Animals
Adult male Wistar albino rats were from the University of Surrey, 
Animal Unit. All rats received food and water ad libitum and were 
maintained on sawdust.
3.2.2 Materials
Dithiothreitol (DTT), phenylmethylsulphonylfluoride (PMSF), acid 
phosphatase and triton X-100 were purchased from Sigma . Diphenylamine 
and 4-nitrophenol phosphate were from BDH and 2-(p-iodophenyl) 
-3-(p-nitrophenyl)-5-tetrazolium chloride was from Koch-Light. All other 
chemicals used were as listed in chapter 2.
3.2.3 Isolation of rat liver nuclei
Nuclei were isolated by a modification of the method of Lynch et al., 
(1975). All steps in the isolation procedure were performed at 4°C.
Adult male Wistar albino rats were killed by cervical dislocation. 
Livers were washed in 0.3M sucrose and each liver suspended with one 
stroke of a loose-fitting Dounce homogenizer in 0.3M sucrose containing 
4mM CaCl2, 2.5mM MgCl2, 0.5mM DTT and O.lmM PMSF (lOml/g liver). The 
resulting suspension was then further homogenized in a hand-held glass 
vessel with a loose-fitting rubber pestle (10 strokes). The homogenate 
was filtered through a single layer of bolting cloth (125pm gauze) and 
the filtrate centrifuged at 9000g for 4min in an MSE High Speed 18 
centrifuge. The resultant pellet was suspended in 2M sucrose containing 
ImM CaCl2, 0.5mM DTT, and O.lmM PMSF (18ml per 7g liver) with 5 strokes 
of the loose-fitting Dounce homogenizer. The suspension was then layered 
over 2.2M sucrose containing 2.5mM MgCl2, 0.5mM DTT, and O.lmM PMSF and 
spun at 21000 rev/min for 60min in a Ti60 rotor using a Beckman model 
L5-65B ultracentrifuge.
3.2.4 Purity of nuclei
Isolated nuclei were assessed for purity using phase contrast 
microscopy. Preparations were essentially free of contaminating 
cytoplasmic debris. Approximately 2.7 x 10^ nuclei per g liver could be 
isolated using this method as determined by counting in an improved 
Neubauer counting chamber (Weber, Sussex).
Lysosomal contamination of nuclei, determined by measuring 
4-nitrophenol production from 4-nitrophenol phosphate, by acid 
phosphatase, in the presence and absence of triton X-100, using the 
method of Huggins and Talalay, (1945), was judged to be negligible.
Mitochondrial contamination was assessed by measurement of reduction 
of the dye 'INT' (2-(p-iodophenyl)-3-(p-nit ropheny1)-5-(tet razolium
chloride) to a red formazan by succinate dehydrogenase (Pennington, 
1961). Contamination of the nuclear pellet was less than 1.5% of the 
total succinate dehydrogenase activity found in the 9000g pellet (P^ ).
3.2.5 Preparation of nuclear extracts containing DNA polymerizing 
activity from isolated nuclei.
The general methods used for the extraction of nuclei are described in 
this section. Modifications to these methods are described in section 3.3.
Nuclear pellets derived from 6-7g of liver were suspended in 4ml of 
either
(a) 0.2M sodium phosphate buffer, pH 7.4, containing 2.5mM MgCl^* 0.5mM
DTT and O.lmM PMSF, (phosphate extraction buffer) or
(b) 0.01M Tris-HCl buffer, pH 8.0, containing 2.0M NaCl; 0.5mM DTT and
O.lmM PMSF, (Tris extraction buffer).
Nuclei suspended in phosphate extraction buffer were sonicated (2 x 
15s bursts using a Dawe sonicator, setting 2) immediately prior to 
extraction. Nuclei in Tris or phosphate extraction buffer were extracted 
for 2-4h at 4°C. After this time, the mixtures were dialysed
overnight against at least 13 volumes of the appropriate extraction 
buffer again at 4°C. Finally, the dialysate was centrifuged at
25000rev/min for 25min using a Beckman type 65 rotor in a Beckman model 
L5-65B ultracentrifuge. Supernatant fractions were stored at -80°C.
3.2.6 Ultrafiltration of nuclear extracts
Nuclear extracts were concentrated and further purified by
ultrafiltration using an Amicon 10ml or 50ml cell containing a diaflo
PM30 filter (cut-off at MW=30000), at a temperature of 4°C and
2
applied pressure of 30 lbf/in . Concentrates were stored at -80°C.
3.2.7 Determination of DNA in subcellular fractions
DNA in samples was measured using the method of Burton (1956) and 
summarized as follows:
Subcellular fractions were diluted with perchloric acid (PCA) to 
yield a final PCA concentration of 0.5M. Samples were incubated at 
70°C for 30min to solubilize DNA. After this time the mixtures were
centrifuged ( 2000rev/min for lOmin ) to remove debris. Aliquots of PCA 
extract (0.1-0.5ml) were made up to 1ml with Q.5M PCA and 2ml of Burton 
reagent added (Burton reagent: 100ml glacial acetic acid containing 1.5%
(v/v) concentrated ^SO^, and 1.5% (w/v) diphenylamine; 0,5ml aqueous
acetaldehyde (1.6% w/v) added just before use). Samples were vortexed
thoroughly and incubated in sealed tubes in the dark at 30°C for 24h. 
Absorbance of samples at 600nm was measured using a Pye Unicam SP 1800 
spectrophotometer. A standard curve was prepared using calf thymus DNA 
dissolved in 0.5M PCA at a concentration range of lO-lOOyg/ml.
3.2.8 Determination of protein in subcellular fractions
Protein was measured using the method of Lowry et al., (1951); the 
standard curve was prepared using BSA at a concentration range of 
10-100yg/ml. Absorbance of samples at 700nm was measured using a Cecil 
292 spectrophotometer.
3.2.9 Measurement of polynucleotide synthesis by nuclear extracts
isolated from rat liver nuclei
The reaction mixture was essentially as described in section 2.2.5. 
and contained: ImM dATP (20yl); ImM dGTP (20yl); ImM dCTP (20yl);
IraM dTTP (20yl); 0.32yCi [3H]dTTP; 600mM KCl (25yl); 205mM
Tris-HCl buffer pH 8.0, containing 20.83mM MgCl2 and lOmM
2-mercaptoethanol (60yl) and O.lmM polydA.oligodT, in template buffer
(60yl).
The reaction was initiated by addition of 25yl of nuclear extract, 
yielding a total volume of 250yl. Incubation was at 37°C for l-2h
in a shaking water bath.
The reaction was stopped by placing tubes on ice and 2 x lOOyl was 
sampled from each tube onto DE 81 filter discs which were processed as 
described in section 2.2.6(b).
3.2.10 Measurement of fidelity of polynucleotide synthesis by nuclear 
extracts isolated from rat liver
3
(i) Misincorporation of [ H]dCTP into polydA.oligodT12_lg
3
[ H]dCTP (22.5yCi) was placed in the reaction tube and evaporated
to dryness in a gentle stream of nitrogen as described previously. The
remaining reaction mixture was added (composition as described above, 
3
minus [ H]dTTP with the 'cold' dCTP volume adjusted to yield a final 
dCTP concentration of 80yM and approximately 2500d.p.m./pmol. The total 
reaction volume was made up to 250yl by addition of enzyme preparation 
(nuclear fraction, 25yl) and distilled Ho0. Conditions for incubation 
were as described above.
3 3
(ii) Misincorporation of [ HjdGTP or [ H]dATP into 
polydA.oligodT,^ 10.
This was measured essentially as described in (i) but replacing 
[3H]dCTP with [3H]dGTP or [3H]dATP. The assays for measurement of 
misincorporation were run in parallel with assays for measurement of
3
[ H]dTTP incorporation.
3.2.11 Digestion of polynucleotide products of DNA synthesis by
deoxyribonuclease I
In order to establish that radioactivity, measured bound to DE 81
3filter discs was due to incorporation of [ H]dNTP into polymeric
material, and not due to non-specific binding of non-incorporated 
3[ H]dNTP to filters, the reaction products were subjected to treatment 
by deoxyribonuclease I as follows:
Polynucleotide synthesis was allowed to proceed for 60min under the 
usual conditions; 40yg DNAase I (in 25yl of 50mM Tris-HCl buffer, pH
7.5 containing 5mM MgCl2) was added and incubation continued for a 
further 15min at 37°C. The reaction was stopped by placing the tubes 
on ice and samples were processed as described previously ( section 
2.2.6(b).
3.3 RESULTS AND DISCUSSION
Preparation of nuclei
Nuclei were prepared from normal or regenerating rat liver using a
modification of the method of Lynch et al. (1975),summarized in figure
3.1. Using this method by homogenization in a relatively large volume of
2+
0.3M sucrose (containing low Ca concentration to maintain nuclear
2+
integrity and low Mg concentration for maintenance of DNA 
polymerizing activity) DNA polymerases are retained in the nucleus. All 
manipulations were performed at 4°C and all solutions contained PMSF 
to minimize protease activity. Sedimentation of nuclei through 2.2M 
sucrose yielded nuclei essentially free from cytoplasmic contaminations 
as observed by phase contrast microscopy (figure 3.2).
Extraction of DNA polymerizing activity from nuclei
The nature of the extraction buffer and extraction conditions greatly 
influenced the type of DNA polymerase activity isolated in nuclear 
extracts from normal rat liver. DNA polymerase a, normally associated 
with 'S' phase DNA replication, would be expected to be at a residual low 
level, since very few cells in adult rat liver undergo cell division 
(Craddock, 1981). Thus the predominamt nuclear DNA polymerase is expected 
to be the J3 polymerase. Constitutive levels of this enzyme are present in 
accordance with its postulated role in DNA repair processes (section 1.4).
Nuclei were extracted into phosphate extraction buffer or Tris 
extraction buffer as described in section 3.2.5.,for 2-4h at 4°C. Two 
groups of phosphate extracts and two groups of Tris extracts were 
sonicated prior to extraction.
The resulting suspensions were dialysed overnight versus the 
appropriate extraction buffer to remove low molecular weight components 
likely to interfere in DNA polymerase assays. Dialysates were centrifuged 
at 25000rev/min or 40000rev/min to remove debris. DNA polymerizing 
activity remaining in the supernatant (S2) was measured as described in 
section 3.2.9.
The specific activity of DNA polymerase activity in phosphate 
extracts was in excess of that in Tris extracts by at least 2 fold (table 
3.1). Sonication of extracts probably released membrane bound polymerase 
activity (Baril et al., 1971). The DNA content of phosphate extracts was 
also markedly lower. Tris extracts probably contained large amounts of
Figure 3.1.
Simplified scheme for the preparation of rat liver nuclear extracts
LIVER
Lysosomes
Microsomes
Mitochondria
UF2
Low M.W material 
e.g. some proteins
P,
Nuclear membranes
Debris
S,
1. Gentle homogenization
2. Centrifugation: 9000g, 4'
CRUDE NUCLEAR PELLET
1. Resuspension in 2M sucrose solution.
2. Suspension layered over 2.2M sucrose 
solution.
3. Centrifugation at 21000rev/min. 60'
NUCLEI
1. Resuspension in Tris or phosphate 
extraction buffer.
2. Extraction of nucleir2-4h at 4°C
3. Dialysis overnight
4. Centrifugation: 25Q00rev/min. 25'
NUCLEAR EXTRACT
1.Ultrafiltration
CONCENTRATED NUCLEAR EXTRACT
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Table 3.1.
(a) Methods of preparation of nuclear extracts (S^ ) from 
isolated nuclei (P^)
Extraction buffer Sonication Post-dialysis 
centrifugation 
(rev/min)
phosphate
phophate
phosphate
phosphate
Tris
Tris
Tris
Tris
25000
25000
40000
40000
25000
25000
40000
40000
PL
PLS
PH
PHS
TL
TLS
TH
THS
(b) Effect of extraction conditions on the recovery of DNA polymerase 
activity from isolated nuclei.
Extraction
conditions
Total DNA
polymerase
activity*
dna
in S2 
(ug/ml)
protein 
in Sp 
(ug/ml)
DNA polymerase 
specific 
activity**
PL
PLS
PH
PHS
TL
TLS
TH
THS
580
2843
473
2333
1848
1155
1962
1110
N.D.
87.5
N.D.
25.0
112.5
350.0
287.5
300.0
180
680
140
500
960
1020
960
880
128.9
167.2
135.1
186.6
77.0 
45.3
82.0 
50.5
* [ H]dTTP incorporated (c.p.m./h) into polydA.oligodT. by 25ul of 
S~ derived from equivalent liver masses
** [ HjdTTP incorporated (c.p.m./h) into polydA.oligodT /ug protein 
N.D. = none detectable
chromatin (Kaftory and Fry, 1978; Fry et al., 1980; Chan et al., 1977; 
Chan and Becker, 1979).
The optimum extraction time appeared to be between 2 and 3h (figure 
3.3). The loss of activity associated with longer extraction times was 
probably due to denaturation of protein caused by excessive agitation and 
frothing of the sample. Typical values for the recovery of DNA polymerase 
activity at each stage in the preparation of nuclear extracts are shown 
in table 3.2.
Characterization of DNA polymerizing activity in nuclear extracts
Recent evidence suggests that the various classes of DNA polymerases 
can be distinguished from each other by several criteria, on the basis of 
size, template preference, selective inhibition with sulphydryl reagents, 
pH optimum and salt dependence, (Dube et al., 1978, 1979). However in 
crude extracts, many of these criteria, for instance, size and template 
preference, may give ambiguous results due to the presence of other 
proteins. The effect of sulphydryl reagents N-ethylmaleimide and 
iodoacetamide on DNA polymerizing activity in Tris and phosphate extracts 
accompanied by measurements of pH optima were chosen here to characterize 
the DNA polymerase activity.
pH optimum
DNA polymerizing activity in Tris and phosphate nuclear extracts 
(S^  fraction) was measured as described in section 3.2.9. using 50mM 
Tris-HCl reaction buffer in the pH range from 7.2 to 8.6 units. Results 
are shown in figure 3.4. Although the pH optimum depends to some extent 
on the nature of template‘.primer, the activity in phosphate extracts 
appeared to have an optimum of between pH 8.0 and 8.4. This is indicative 
of a 8-type DNA polymerase (Dube et al., 1978). Optimum pH of polymerase 
activity in Tris extracts was less clear-cut due to an overall low level 
of activity, but appeared to be shifted to a lower pH than the phosphate 
optimum.
Legend to figure 3.3.
N u c l e i  w e r e  e x t r a c t e d  f o r  2 ~ 4h  as  d e s c r i b e d  i n  s e c t i o n  
3 . 2 . 5 .  S a m p l e s  ( 2 5 j u l ) o f  S ( n u c l e a r  e x t r a c t )  w e r e  t h e n  
a s s a y e d  f o r  DNA p o l y m e r i z i n g  a c t i v i t y  a s  d e s c r i b e d  i n  
t h i s  c h a p t e r .  I n c u b a t i o n s  w e r e  p e r f o r m e d  f o r  1 5 - 1 2 0 m i n . 
C o n t r o l s  d i d  n o t  c o n t a i n  p o l y d A . o l i  g o d T .
E x t r a c t i o n  t i m e s :
© © 2h  /  !![• fg 3.5/7; & ----- k^h
J P oB T IO ‘ {/p fi IO d  OQ.UT p3Q.BJOdjOOU T d l lP ^H gT ^
Fi 
gu
re
 
3
.3
. 
Th
e 
e
ff
e
c
t 
of
 
tim
e 
of
 
e
x
tr
a
c
ti
o
n
 
on 
th
e 
re
co
ve
ry
 
of
 
DM
A 
p
o
lg
m
e
ri
 
zi
ng
 
a
c
t
i
v
i
t
u
 
in
 
ra
t 
li
v
e
r 
n
u
cl
e
a
r 
e
x
tr
a
c
ts
.
Table 3.2.
Typical recovery of DNA polymerizing activity in subcellular fractions 
from normal rat liver
Fraction* DNA polymerase 
2
D M  polymerase
(Total activity) (specific activity)'
4.2 0.78
22.37 2.78
43.74 212.58
41.17 351.48
1.93 22.43
Notes:
1. see figure 3.1 for key
2. nmol [ H]dTTP incorporated/h into polydA.oligodT /g liver
3
3. [ H]dTTP incorporated (c.p.m./h) into poldA.oligodT /ug protein
Legend to figure 3.4.
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Effect of N-ethylmaleimide
Phosphate and Tris nuclear extracts (S2 fraction) were assayed for 
DMA. polymerizing activity in the presence of 0.1-10mM N-ethylmaleimide in 
the reaction mixture (figure 3.5). Activity in the Tris extract dropped 
sharply to 50% of the control activity in the presence of O.lmM 
N-ethylmaleimide but did not drop further in concentrations up to lOmM. 
Activity in phosphate extracts was not inhibited by O.lmM 
N-ethylmaleimide. Activity gradually fell to 50% with increasing 
concentrations of N-ethylmaleimide.
DNA polymerase a activity is extremely sensitive to 
N-ethylmaleimide, purified preparations being 90-100% inhibited by 
concentrations as low as O.lmM (Chan and Becker, 1981; Weissbach, 1975; 
Loeb et al., 1977). Polymerase B is relatively insensitive to
N-ethylmaleimide at this concentration. Thus it appears that the sharp 
drop in activity associated with the Tris extract on exposure to O.lmM 
N-ethylmaleimide is due to presence of low levels of DNA polymerase a 
activity. Phosphate extracts were judged to be free from contaminating 
polymerase a activity.
These findings are in agreement with the data of Craddock (1981), who 
found that a 200mM phosphate extract of nuclei from regenerating liver, 
yielded mainly polymerase B activity, whereas lOmM Tris extracts yielded 
a polymerase activity.
3
Characteristics of [ H]dTTP incorporation into polydA.oliqodT by 
nuclear extracts
3
Incorporation of [ HjdTTP into polymeric material by nuclear 
extracts (S2) from normal rat liver (derived from nuclei which had been 
sonicated and extracted into 200mM phosphate buffer) was linear for at 
least 90min (figure 3.6). Under the conditions used for the assay,
3
maximal incorporation of [ HjdTTP occured after 240min. Addition of 
excessive quantities of pancreatic deoxyribonuclease I at various time 
intervals, led to degradation of newly synthesized polymeric material. 
The presence of low levels of endogenous DNA in the extracts did not 
support polymerase activity in the absence of polydA.oligodT.
Legend to figure 3.5.
S a m p l e s  (25j j 1 )  o f  S p h o s p h a t e  e x t r a c t e d  n u c l e i  a n d  
T r i s  e x t r a c t e d  n u c l e i  w e r e  i n c u b a t e d  i n  t h e  p r e s e n c e  
o f  r e a c t i o n  m i x t u r e  c o n t a i n i n g  O . l - l O m M  N - e t h y l m a l e i m i  de 
C o n t r o l s  (100% a c t i v i t y )  d i d  n o t  c o n t a i n  N - e t h y l m a l e i m i d e .  
B l a n k s  d i d  n o t  c o n t a i n  p o l y d A . o l i  g o d T .  S a m p l e s  ( l O O j u l )  
o f  r e a c t i o n  m i x t u r e  w e r e  a s s a y e d  f o r  [■ZfQdTTP i n c o r p ­
o r a t i o n  i n t o  p o l y m e r i c  m a t e r i a l  a f t e r  SOmin  a t  3 7 ° C. 
R e s u l t s  a r e  t h e  mean o f  2 d e t e r m i n a t i o n s .
© ---------------- ©  P h o s p h a t e  e x t r a c t e d  n u c l e i ;
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Legend to figure 3.6.
S a m p l e s  (25jj1) of S P h o s p h a t e  e x t r a c t  f r o m  n o r m a l  r a t  l i v e r  
n u c l e i  w e r e  i n c u b a t e d  a t  37 C f o r  6 0 - 2 4 0 m i n  w i t h  c o m p l e t e  
r e a c t i o n  m i x t u r e .  D u p l i c a t e  s a m p l e s  w e r e  t r e a t e d  w i t h  DNAase  
I  a t  h o u r l y  i n t e r v a l s  a s  d e s c r i b e d  i n  s e c t i o n  3 . 2 . 1 1 .  
R a d i o a c t i v i t y  r e m a i n i n g  i n  n e w l y  s y n t h e s i z e d  p o l y m e r i c  m a t e r i a l  
1 5 m i n  l a t e r  was m e a s u r e d .  T r i s - H C l  ( 5 0 m M ) , p H  7 . 5  c o n t a i n i n g  
5mM MgCl  o n l y  was a d d e d  t o  c o n t r o l s  i n  p l a c e  o f  DNAase I .  
R e s u l t s  a r e  t h e  mean o f  2 d e t e r m i n a t i o n s . The i n c o r p o r a t i o n  o f  
\j?N~]dTTP i n  t h e  a b s e n c e  o f  t e m p l a t e  was 5 p m o l  a f t e r  24C!min.
® w i t h o u t  DNAase I ;
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Effect of partial hepatectomy on the amount of DNA polymerizing activity 
in nuclear extracts
It is well established that restorative hyperplasia, stimulated as a 
result of partial hepatectomy of adult rat liver, is accompanied by a 
large increase in the activity of DNA polymerase a (Chang and Bollum, 
1972; Lynch et al., 1975). The increase in activity of this polymerase 
isolated from cytoplasm was nearly 7-fold after a 48h period of 
regeneration. However, there is also a small increase (2-3 fold) in the 
low molecular weight nuclear enzyme, £ polymerase (Chiu et al., 1974); 
Gerwin et al., 1976). The reason for this small yet significant increase 
is probably associated with the role of B polymerase in replicative 
synthesis as a 'gap-filling' enzyme. Short stretches of DNA, Okazaki 
fragments, are joined up by the enzyme during normal replication when RNA 
initiators have been removed (Okazaki et al., 1968).
In experiments presented here, B-type polymerase activity, isolated 
from 7-day and 14-day regenerated livers was compared to that isolated 
from normal intact animals. Recoveries of polymerase activity in nuclear 
extracts are shown in table 3.3. ,
Effect of N-ethylmaleimide on DNA polymerase activity in nuclear extracts 
from normal and regenerating rat liver
Nuclear extracts (UF^ ) in 2Q0mM phosphate buffer from control, 7-day 
regenerated and 14-day regenerated liver were assayed for DNA 
polymerizing activity in reaction mixture containing 0.1-10mM 
N-ethylmaleimide. Results are shown in figure 3.7. Profiles obtained for 
each enzyme fraction were almost identical, yielding 30-40% inhibition of 
enzymic activity at lOmM N-ethylmaleimide.
Effect of iodoacetamide of DNA polymerizing activity in nuclear extracts
Iodoacetamide is known to react with the thiol groups of proteins. 
Thus the extent of inhibition will be indicative of a particular class of 
DNA polymerase. Iodoacetamide was present in reaction mixture for the DNA 
polymerase assay at concentrations of 1-lOOmM. Results are shown in 
figure 3.8.
Inhibition by iodoacetamide is approximately 50% at lOOmM 
concentration in normal and 7-day regenerated liver samples. Chan and 
Becker (1981) have reported that purified DNA polymerase B from 24h
Table 3.3
The effect of partial hepatectomy* on total DNA polymerizing activity in 
nuclear extracts from rat liver
Control
liver
7-day regenerated 14-day regenerated 
liver liver
Mean liver mass 7.02+0.57 
(g) (n=12)
5.55+0.58
(n=6)
5.92+0.55
(n=6)
DNA polymerase 
activity/g liver 
(% of control)
100.00 109.54 104.00
* 70% Partial hepatectomies were performed on weight-matched rats at 240g.
Legend to figure 3.7.
S a m p l e s  ( 2 5 p l )  o f  UF f r a c t i o n  f r o m  n o r m a l ,  7 - d a y  a n d  
1 4 - d a y  r e g e n e r a t e d  l i v e r s  w e r e  i n c u b a t e d  i n  r e a c t i o n  
m i x t u r e  c o n t a i n i n g  0 . 1 - l O m M  N - e t h y l m a l e i m i d e . R a d i o a c t i v i t y  
i n  1 0 0 / jI a l i q u o t s  w a s  m e a s u r e d  as  d e s c r i b e d  i n  s e c t i o n  2 . 2 . 6 .  
C o n t r o l s  (1 00%  a c t i v i t y )  d i d  n o t  c o n t a i n  N - e t h y l m a l e i m i d e .  
B l a n k s  d i d  n o t  c o n t a i n  p o l y d A . o l i  g o d T .  The DNA p o l y m e r a s e  
a c t i v i t y  ( p m o l  \^H ~ \dT T P  i n c o r p o r a t e d  / h  i n t o  p o l y d A . o l i  g o d T )  
i s  e x p r e s s e d  a s  a % o f  c o n t r o l  DNA p o l y m e r a s e  a c t i v i t y  a n d  
r e p r e s e n t s  t h e  mean o f  2 d e t e r m i n a t i o n s .
( a )  n o r m a l  l i v e r
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Legend to figure 3.8.
S a m p l e s  ( 2 5 j u l )  o f  UF f r a c t i o n  f r o m  n o r m a l ,  7 - d a y  a n d  
1 4 - d a y  r e g e n e r a t e d  r a t  l i v e r s  w e r e  i n c u b a t e d  i n  r e a c t i o n  
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i n  100/ j I  a l i q u o t s  w a s  m e a s u r e d  as  d e s c r i b e d  i n  s e c t i o n  
2 . 2 . 6 .  C o n t r o l s  (100% a c t i v i t y )  d i d  n o t  c o n t a i n  i o d o a c e t a m i d e .  
B l a n k s  d i d  n o t  c o n t a i n  p o l y d A . o l i g o d T .  The DNA p o l y m e r a s e  
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regenerated rat liver was inhibited by 25% after exposure to 30mM 
iodoacetamide. This is in agreement with the results shown here using 
crude polymerase preparations. Thus the activity can be assigned as non 
a-type since this activity has been reported, by the same authors, to 
be inhibited by over 80% in the presence of 30mM iodoacetamide.
Fidelity of D M  polymerizing activity in nuclear extracts isolated from 
normal and regenerating rat liver
Concentrated nuclear extracts (UF^ in 200mM phosphate extraction
buffer were used in the fidelity assay to provide a substantial level of
activity for measurement of non-complementary nucleotide insertion into
polydA.oligodT as described in section 3.2.10. Template-.primer and
deoxynucleotide samples were first tested with E.coli DNA polymerase I,
3to assess the level of purity of non-complementary [ H]dNTPs. Typical
results are shown in chapter 2. Duplicate samples from each nuclear
3 3extract were assayed for the incorporation of [ H]dTTP, [ H]dCTP or
3
[ H]dGTP into polymeric material in the presence and absence of 
2-mercaptoethanol in the reaction buffer. Results are shown in tables 3.4 
and 3.5.
Error rates for the enzyme isolated from normal, 7-day regenerated 
liver and 14-day regenerated liver were not significantly different. 
Absence of the sulphydryl reagent in the reaction buffer did not affect 
the fidelity. This is in agreement with the observation by Chan and 
Becker,(1981), who reported that the thiol groups of DNA polymerases play 
no part in substrate binding or the actual catalytic reaction; although, 
as shown here, N-ethylmaleimide and iodoacetamide inhibited the activity 
to some extent. The importance of the thiol groups in catalysis may be in 
maintaining the enzyme in an active conformation or in controlling the 
activity in vivo. It is unlikely that the high error rates observed here 
are due to the presence of terminal deoxynucleotidyl transferase in the 
nuclear extracts since to date, this enzyme has only been detected in 
tissues such as thymus and bone marrow (see chapter 1.4). Also, since the 
polymerization reaction involving this enzyme is random and not template
3
directed, error rates for each [ H]dNTP would be expected to be 
identical when equal concentrations of dNTPs are present in the reaction 
mixture. This is clearly not the case here. However the high error rates 
observed here are surprising, yet similar error rates have been measured 
in partially purified B polymerase preparations from human placenta 
(table 3.6). Krauss and Linn (1980) isolated 2 subspecies of B polymerase
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Table 3.6.
Fidelity of some DMA polymerases B
Source Template Error rate Referenc
HeLa polydA.oligodT 1/17000 (a)
HeLa polydT.oligodA 1/3100 (a)
HeLa polydl.polydC. 1/12000 (a)
HeLa polydC.oligodG 1/8800 (b)
Calf thymus polyA.oligodT 1/180000 (c)
Calf thymus polyd(A-T) 1/11800 (e)
Human placenta polydA.polydT 1/730 (d)
Human placenta polyd(A-T) 1/200 (d)
Human placenta B2 polydA.polydT 1/3700 (d)
Human placenta B2 polyd(A-T) 1/200 (d)
Calf liver polyd(A-T) 1/15200 (e)
mouse liver polyd(A-T) 1/1070 (f)
chromatin*
Human lymphocyte polyd(A-T) 1/1490 (f)
chromatin*
Transformed polyd(A-T) 1/150 (f)
lympocyte chromatin*
(a) Krauss and Linn,(1982).
(b) Radman et al.(1977).
(c) Chang,(1973).
(d) Krauss and Linn,(1980).
(e) Dube et al.(1979)
(f) Fry et al. (1980).
* Denotes DNA polymerase B activity of chromatin, not of purified enzyme
designated B^ and B2 from nuclei of fresh human placenta. Error rates
in excess of 1/200 were calculated for the enzyme copying the
2+heteropolymer polydA-dT, in the presence of Mg . High error rates have 
also been measured for B polymerases isolated from human fibroblast 
cultures in various passages (Krauss and Linn, 1982). DNA polymerase B 
activity in vivo is probably a limited addition reaction (gap-filling
activity) due to the low concentration of 3'-OH groups available as
primer portions for catalysis. In vitro very high concentrations of 3'-OH 
primer termini would be available for the enzyme. Thus the likelihood of 
errors not being corrected in vitro is high unless exonucleases and other 
corrective enzymes are present in the nuclear extract.
DNA polymerases, B, obtained from a variety of sources show diverse
fidelities in copying various types of synthetic template (see table
3.6). In general, for polymerization to occur, each polymerase requires a
minimum template:primer length ratio. DNA polymerases B are known, to
polymerize template:primers which contain 1-3 terminally mispaired
nucleotides. The recognition and binding to such templates is enhanced by
2+ 2+the replacement of Mg with Mn leading to increased fidelity (Wang 
and Korn, 1982). Fidelity may also be increased by reducing the 
concentration of non-complementary nucleotides relative to complementary 
nucleotides in the reaction mixture (Krauss and Linn, 1980), thus 
accounting for the diversity of error rates. This diversity in fidelities 
may also explain why slightly different tryptic peptide maps are obtained 
from various mammalian DNA polymerases, despite almost identical 
molecular weights (Tanabe et al., 1981).
Much evidence suggests that DNA polymerase B functions in DNA repair 
(Wicker et ajL., 1979; Wawra and Dolejs, 1979; Siedlecki et al., 1980; 
Rossignol et al^ ., 1980; Nowak et^  al., 1980). Thus if the low fidelity of 
nuclear extracts observed in vitro is a true reflection of the fidelity 
of DNA polymerases in vivo, then relatively error-free DNA replication or 
repair may be achieved by successive rounds of mismatch repair as 
suggested by Loeb and Kunkel (1982). This process may not be evident in 
systems using synthetic polynucleotides.
In summary, phosphate extraction of nuclei from normal rat liver 
yielded high levels of DNA polymerase activity, characterized as B-type 
on the basis of pH and inhibition by sulphydryl reagents. Similar, if not 
identical activity was obtained from 7- and 14-day regenerated rat liver. 
The use of regenerating liver as a source of the nuclear extract was not
pursued since the total activity obtained in 7- and 14-day regenerated
livers, was not significantly higher than controls. The fidelity of DNA 
polymerizing activity was low compared to that obtained for purified 
enzymes but may be a better reflection of fidelity in vivo.
CHAPTER 4
THE EFFECT OF IN VIVO AND IN VITRO ADMINISTRATION OF GENOTOXIC 
ALKYLATING AGENTS ON DNA POLYMERASE B ACTIVITY AND FIDELITY.
4.1 INTRODUCTION
Alkylating agents form a large class of chemical compounds which 
react with cellular components, DNA, RNA and protein. Alkylation 
reactions involve nucleophilic substitution at the electrophilie carbon 
atom of the alkylating agent. There are two reaction mechanisms normally 
applicable to alkylating agents: SN^ type and SN2 type.
In an SN^ type reaction, the alkylating agent undergoes a 
dissociation and the carbonium ion (alkylating species) thus formed is 
rapidly attacked (see equation 1).
R - X
alkylating agent
R+ + R'
The mechanism of an SN^ reaction is demonstrated in equation 2.
6-  6+
R' + R - X
alkylating 
agent
Many alkylating agents, either directly-acting or acting after 
metabolic activation show varying activity as carcinogens and mutagens. 
Interest in these compounds was aroused in the 1960's when it was 
generally believed that alkylation of guanine in DNA at the N-7 position 
was biologically significant in leading to genetic changes which could 
cause neoplastic transformation (Lawley and Brookes, 1961; Lawley, 1966). 
Many groups of alkylating agents produce alkylating species which react 
primarily at the N-7 positiori of_guanine*_£or example, the alkyl_meJ:hane 
sulphonates and N-nitroso compounds. It is now known that carcinogenesis 
is unlikely to result solely from this reaction, since the agents produce 
a wide variety of alkylated bases in RNA and DNA (Pegg, 1977; Margison 
and O'Connor, 1979; O'Connor et al., 1979) as well as modifying proteins 
and lipids in vivo and in vitro.
[ R‘ - R ] + X equation 2
-St™ * R+ + X
equation 1
JiASi -- ^ [ R _ r . j +
N-nitroso compounds.
N-nitroso compounds can be divided into two main classes, The 
N-nitrosamides (I) and the N-nitrosamines (II).
0
R1 C R
N   N =  0 N  N = 0
R. C R.2 I 2
0 (I) (II)
The N-nitrosamides are generally unstable at physiological pH and 
hydrolyse spontaneously to yield reactive species. The breakdown in vitro 
can take place in the absence of added thiols but in vivo it is expected 
that the alkylating species would be derived via a thiol-mediated pathway 
(Margison and O'Connor, 1979; Lawley and Thatcher, 1970).
The nitrosamines (exemplified here by DMN) are chemically stable 
under physiological conditions and only exert their adverse biological 
effects after metabolic activation. Activation requires 0^ and NADPH 
and is localized entirely in the microsome plus cytosol fraction (Heath, 
1962; Lai and Arcos, 1980). The activation process is generally thought 
to preceed by a-hydroxylation (figure 4.1) mediated by cytochrome P450. 
However some recent evidence has suggested that the activation may 
proceed through N-oxidation by a monoamine oxidase activity (Gangolli, 
1981). The resultant carbonium ion is thought to be involved in 
macromolecular binding.
Experiments with fully deuterated methyl groups (-CD^) have shown
that the methyl group is transferred intact by an SN^ type mechanism to
the appropriate base or amino acid residue (Lijinsky et al., 1968).
Similar a-hydroxylation takes place on one of the ethyl groups of
diethylnitrosamine (DEN) producing ethyl carbonium ion (C2H5^
which can also react with DNA, RNA and protein. The mechanism by which
cyclic nitrosamines and higher dialkyInitrosamines for example,
di-n-propylnitrosamine (DPN) and di-n-butylnitrosamine (DBN) are
activated is uncertain. Kruger (1971) has isolated N-7 propyl and N-7
14butyl guanine from liver RNA after in vivo metabolism of l-[ C]
14di-n-propylnitrosamine and l-[ C] di-n-butylnitrosamine indicative of 
an a-hydroxylation pathway. A B-oxidation pathway analagous to fatty 
acid B-oxidation has also been proposed by Kruger (1971) to account for 
metabolic activation of DPN and DBN.
Some sites of base alkylation in nucleic acids after treatment with
Postulated pathway for the metabolic activation of dimethylnitrosamine,
CH,
\ CH-
CH/
N  N = 0  NADPH
Q,
h 2c
 N = 0
\ OH
-HCHO
CH.
N2
T S *  CHj - N = N  «£. -OH'
V
CH* 
/  3I
V .
H O  N =  N — CH-
F i g u r e  4 . 2 .
The r e a c t i o n  o f  R-p r o p i o l a c t o n e  w i t h  n u c l e o p h i l e s
nitrosamines or nitrosamides are shown in figure 1.4. Magee and Hultin 
(1962) have shown that in vitro incubation of DMN with liver slices led 
to methylation of proteins at N-l and N-3 of histidine. Turberville and 
Craddock (1971) later showed methylation of histones by DMN on histidine 
residues and to a lesser extent on cysteine residues. There is very 
little information regarding alkylation of proteins by higher alkyl 
groups derived from dialkylnitrosamines.
N-nitroso compounds have very different toxicities associated v/ith 
their different chemical stabilities, yet about 80% of these compounds 
studied in rats have been shown to be carcinogenic (Druckrey et al., 
1967; Magee and Barnes, 1967). N-nitrosamides generally induce damage at 
the site of application and in organs v/ith rapid cell turnover. 
N-nitrosamines exert damage at sites of metabolism.
The acute toxicity of dialkylnitrosamines appears to decrease with 
increase in alkyl chain length (Druckrey et al_., 1967; Heath, 1962; Pour 
et al., 1973; Shank, 1975). The reason for this in vivo is unclear but in 
vitro, may be associated with lipid peroxidation leading to limited 
viability of microsomal enzymes (in Arne's tests), thus hampering the 
conversion of longer-chain nirosamine derivatives to mutagens (Montesano 
and Bartsch, 1976).
Alkane methane sulphonates
Alkylating agents of this class have the general formula (III)
0
I!
RO —  S  CH0 (III)
I 3
0
The alkylating species R is produced by an- SN£ mechanism. 
Compounds of this class do not require metabolic activation to exert 
their effect. The sites of alkylation of DNA and RNA by MMS, the simplest 
members of this class are at N-l, N-3 and N-7 of adenine; N-3 and N-7 of 
guanine and N-3 of cytosine (Margison and O'Connor, 1979; O'Connor et 
al., 1979). The extent of reaction of MMS v/ith protein is greater than 
the reaction with DNA (Craddock et al., 1976).
fi-lactones
The B~lactones for example B-propiolactone (BPL (IV) alkylate DNA, 
RNA and protein by an SN^ mechanism (figure 4.2). The result of the 
reaction is a carboxyethyl derivative of the nucleophile. The major site
of attack on DNA and RNA is at N-7 of guanine. Some minor alkylation 
products have also been detected in adenine. The major stable reaction 
product with protein is S-2 carboxyethyl cysteine (Boutwell et al., 1969; 
Colburn and Boutwell, 1968). Despite its short half-life in vivo (less 
than 3h), B-propiolactone is a potent skin carcinogen (Colburn
:£><=■ ui-_ioe\\ } (=><3}•
There has been extensive research on the modification of DNA and RNA 
by alkylating agents (Margison and O'Connor, 1979; Pegg, 1977; Lawley, 
1972). A common feature of the alkylating carcinogens DMN, DEN, and MNNG 
is the alkylation of 0-6 of guanine in DNA. This alkylated base has been 
shown to induce miscoding in vitro by DNA polymerases (Abbot and
Saffhill, 1977).- The possible importance of 0-6 alkylation was first 
suggested by Loveless (1969). However, the presence, stability and
persistence of modified bases in DNA does not appear to correlate with 
carcinogen activity (Pegg, 1977; Margison e^t al., 1977; Scherer et al., 
1977), especially since they are removed by repair in most cases 
(although error-prone repair does take place; see chapter 1). In many 
cases the reaction of alkylating agents with protein exceeds the reaction
with DNA (Gronow, 1980). It is suprising that the possible biological
consequences of the reaction with specific proteins has not been studied 
in as great detail as the reaction with DNA.
In the following chapter, the effect of in vivo administration of a 
series of N, N-dialkylnitrosamines on rat liver nuclear DNA polymerase B 
activity and fidelity has been studied in relation to the In vitro effect 
of various alkylating agents on DNA polymerase B activity.
4.2 MATERIALS AND METHODS.
4.2.1 Materials.
Dimethylnitrosamine, dipropylnitrosamine, dibutylnitrosamine, 
dimethyl sulphoxide and N-ethylmaleimide were obtained from Sigma. 
Diethylnitrosamine was from Eastman, methyl methane sulphonate and 
N-methyl-N-nitro-N-nitrosoguanidine were from Aldrich and B-propiolactone 
was from Fluka. All other chemicals used were as listed in previous 
chapters.
4.2.2 In vitro modification of DNA polymerase activity by alkylating 
agents.
The following stock solutions of alkylating agent were prepared less 
than lh before use and stored in the dark until required.
lOOmM B-propiolactone in distilled water;
2000mM Methyl methane sulphonate in distilled water;
50mM N-methyl-N-nitro-N-nitrosoguanidine in a dimethyl 
sulphoxide:distilled water mixture (0.025:1).
Duplicate, 200yl samples of enzyme (nuclear extract UF^ prepared 
from normal rat liver as described in chapter 3.2 or 1 unit E.coli DNA 
polymerase I) were treated with 0-50yl of alkylating agent stock, and 
the total volume made up to 250yl with distilled water. Samples were 
pre-incubated at 37°C for 30min in sealed tubes. After this time, 
samples were dialysed extensively against 0.2M sodium phosphate buffer, 
pH 7.4, containing 2.5mM MgCl^ and 0.5mM dithiothreitol or enzyme 
dilution buffer (section 2.2) where E.coli DNA polymerase I was used. 
Dialysis was for 3-4h at 4°C. Enzyme samples not treated with 
alkylating agent, but taken through identical procedures served as 
controls (100% activity).
Aliquots (25yl) of modified or mock-modified enzyme were assayed 
for DNA polymerase activity and fidelity using the assay methods 
described in section 3.2 for rat liver nuclear extracts and in section 
2*2 for E.coli DNA polymerase I.
4.2.3 In vivo administration of N-N, dialkylnitrosamines
Weight-matched male Wistar albino rats (18Q-2G0g) were allowed food 
and water ad libitum. Test animals were dosed i.p. with either 36mg/kg 
dimethylnitrosamine (DMN) in 0.9% (w/v) NaCl; or 50mg/kg
diethylnitrosamine (DEN) in 0.9% (w/v) NaCl; or 64mg/kg
dipropylnitrosamine (DPN) in corn oil; or 78mg/kg dibutylnitrosamine 
(DBN) in corn oil. Dosing solutions were prepared less than 24h before 
use and stored in the dark at 4°C. Control animals for each group 
received equivalent volumes of either corn oil or 0.9% (w/v) sodium
chloride. All animals were dosed at 9:00 am to minimize possible diurnal 
variations . in DNA polymerase B activity except animals to be killed 16h 
after dosing (dose received at 5:00 pro).
At 2, 5, 8, 16 and 24h after dosing, 4 animals from each group were 
killed by cervical dislocation. A liver sample (6g) was removed from each 
animal and nuclear extracts were prepared as described in section 3.2. 
DNA polymerase B activity in nuclear extracts (S2) were determined as 
described in section 3.2 except that the reaction mixture contained ImM 
N-ethylmaleimide in place of 2-mercaptoethanol to inhibit any reaction 
due to contaminating DNA polymerase a activity. Fidelity assays were 
performed on nuclear extracts (S^ ) as described in methods 3.2.
4.2.4 In vivo administration of MMS
Groups of 3 control animals and 3 test animals (weight-matched at 
220-240g) were allowed food and water ad libitum throughout the course of 
the experiment. Test animals received a single dose i.p. of MMS (60mg/kg 
body weight) in 0.9% (w/v) NaCl 24h before killing. A further dose of MMS 
(60mg/kg body weight) was administered 4h later. Controls received an 
equivalent volume of 0.9% (w/v) NaCl at the same time intervals. Animals 
were killed by cervical dislocation 20h after receiving the second dose. 
A liver sample (7g) was removed from each animal and nuclear extracts 
were isolated as described in section 3.2. DNA polymerase B assays on 
nuclear extracts were performed in the presence of ImM N-ethylmaleimide.
4.3 RESULTS AND DISCUSSION
Effect of alkylating agents on DNA polymerase B activity and fidelity 
in vitro.
DNA polymerase B activity in nuclear extracts or E.coli DNA 
polymerase I were exposed to increasing concentrations of MMS, MNNG or 
BPL at 37°C. Unmodified enzyme samples incubated at 37°C for 
30min prior to addition of DNA polymerase reaction mixture, retained over 
50% of the activity of non-incubated enzyme samples (figure 4.3). 
Therefore a 30min preincubation period was chosen for the in vitro 
reaction of alkylating agents with DNA polymerases, which would allow 
sufficient reaction time without natural denaturation of the enzyme.
Inhibition of DMA polymerase activity by alkylating agents.
MNNG appeared to be a very potent inhibitor of DNA polymerase B 
activity. Exposure to lOmM MNNG in vitro reduced the activity to 20% of 
the activity of mock-modified controls (figure 4.4). The effect of 
B-propiolactone and M S  was less severe. DNA.polymerase B still retained 
20% of the activity of mock-modified controls on exposure to 50mM BPL 
(figure 4.5). MMS at 200raM resulted in a 70% inhibition of the DNA 
polymerase B activity. It was interesting to observe the mammalian 
polymerase activity was more susceptible to M S  than E.coli DNA 
polymerase I (figure 4.6). Inactivation of E.coli DNA polymerase I by MMS 
appeared to be biphasic. This is in agreement with the findings of 
Saffhill (1974), who discovered a similar biphasic inactivation of the 
enzyme by dimethyl sulphate. The reason for this is not understood but 
may be associated with the 3'—5‘ and 5'-3' exonuclease activity 
associated with this enzyme.
The fidelity of enzyme samples modified in vitro by alkylating agents 
was measured using the methods described previously (section 3.2). 
Results are shown in tables 4.1; 4.2; 4.3. The error rate (in each
experiment) of the mock-modified enzyme was between 1/700 and 1/800 for
3
[ H]dCTP incorporation into polydA.oligodT. No significant alteration 
in fidelity compared to controls was observed on exposure of DNA 
polymerase B activity to 1.25mM BPL. No errors were detectable at 12.5mM 
BPL.
Exposure of DNA polymerase B activity to low concentrations of M S  
and MNNG (5mM and ImM respectively) resulted in an almost three-fold
Legend to figure 4.3.
One u n i t  o f  E. c o l i  DNA p o l y m e r a s e  I  i n  2 5 0 ju l o f  e n z y m e  d i l u t i o n  
b u f f e r  w a s  p r e i n c u b a t e d  f o r  0 - 6 0 m i n  a t  3 7 °C i n  a  s h a k i n g  w a t e r  
b a t h .  2 5 ju l s a m p l e s  w e r e  r e m o v e d  a t  v a r i o u s  t i m e  i n t e r v a l s  a n d  
t h e  a c t i v i t y  o f  t h e  e n z y m e  on  p o l y d A .  o l i g o d T .  w a s  d e t e r m i n e d  b y  
t h e  s t a n d a r d  a s s a y  m e t h o d  ( s e c t i o n  2 . 2 . 5 . ) .
DNA p o l y m e r a s e  a c t i v i t y  i s  e x p r e s s e d  as  a p e r c e n t a g e  o f  t h e  
c o n t r o l  u n i n c u b a t e d  en z y m e  a c t i v i t y (10 0%  v a l u e ) .
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increase in fidelity. No errors were detectable on exposure to higher
concentrations of these agents (50mM and 5mM respectively). No
3
misincorporation of [ H]dGTP into polydA.oligodT by DNA polymerase B
exposed to these agents was detected.
In vitro modification of E.coli DNA polymerase I by MMS (50mM) did
however, result in decreased fidelity of the enzyme copying
3
polydA.oligodT (table 4.4). For [ H]dCTP incorporation, the increase in
3
error rate was from 1/5900 to 1/3600 and for [ H]dGTP incorporation, 
the increase in error rate was from 1/24000 to 1/18000. The infidelity of 
this enzyme on exposure to MMS may be due to inhibition of the 3‘ —5' 
exonuclease activity. Methylation of this portion of the enzyme complex 
may reduce the ability of the 3'-5' exonuclease to excise
non-complementary-nucleotides from polydA.oligodT as they are inserted by 
the polymerase activity; thus giving rise to higher error rates. This 
phenomenon has also been observed after treatment of this enzyme in vitro 
with N-methyl N-nitrosourea (Saffhill, 1974).
The general inhibition of DNA polymerase activity following exposure 
to alkylating agents in vitro, is in agreement with th$e observations of 
Chan and Becker (1981) and Anderson and Burdon (1970). Similar inhibition 
of RNA polymerase activity has been observed following exposure to MMS in 
vitro (Herzog and Farber, 1976).
The way in which alkylating agents exert their effect on DNA
polymerases is unclear. Attack on particular amino acid residues may 
alter the structure of the polymerase such that:
(a) the template binding affinity of the enzyme is altered,
(b) binding sites of template, primer and deoxynucleotides are blocked,
thus reducing the total level of DNA synthesis,
(c) metal ion binding to the polymerase may be blocked or altered, 
leading to alterations in fidelity.
The major sites of attack by MMS and BPL in protein are at cysteine 
residues (Turberville and Craddock, 1971; Boutwell et al., 1969).Some
attack may occur on the oxygen atom of carboxyl groups, the ring nitrogen 
atom of histidine and at the terminal amino group and the e-amino group 
of lysine (Miller and Miller, 1966).
Studies on the alkylation of DNA polymerase a activity in 
cytoplasmic extracts from hamster fibroblasts by MNNG, have shown that 
pre-incubation of enzyme and alkylating agent in the presence of 
glutathione or 2-mercaptoethanol protects against the effect of this
agent. Lysine and histidine also had a protective effect but the reaction
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with MNNG was also shown to be irreversible (Anderson and Burdon, 1970).
The guanidium moiety of MNNG has been shown to attack protein 
preferentially to DNA (Sugimura et al., 1968). DNA polymerase a has
been postulated to be rich in lysine residue which are involved with 
binding of the polymerase to DNA (Erhan, 1968). Attack on these lysine 
residues by MNNG would possibly alter the affinity of the polymerase for 
DNA. Reduced DNA binding capacity could therefore explain the inhibition 
of DNA polymerase activity by MNNG. Validation of this has not been 
possible since the scarcity of homogeneous preparations of DNA 
polymerases has made amino acid analyses virtually impossible; yet it is 
likely that binding to DNA by other DNA polymerases may occur through a 
similar mechanism. Also, alkylation by the methyl group of MNNG must 
contribute to the inhibition due to similar effects on fidelity as MMS.
The apparent increase in fidelity observed in vitro on exposure of 
DNA polymerase B to high concentrations of these alkylating agents may 
result from altered template:primer binding properties. In this case, due 
to interaction of the agent at specific sites on the enzyme, the 
conformation of the nucleotide binding site may be held rigid, thus only 
allowing incorporation of the nucleotides with the exact fit. As a result 
of this, the enzyme-template complex becomes highly selective regarding 
the nature of the new nucleotide to be added onto the primer portion. An 
extreme result of this would be such high selectivity that DNA
polymerization would cease.
Effect of in vivo administration of MMS on the level and fidelity of DNA 
polymerase B activity.
The high reactivity of MMS with cell water and other tissue 
constituents probably accounts for the low toxicity of this compound in 
vivo. Administration of sublethal doses (less than 120mg/kg body weight) 
to rats has been postulated to elicit a DNA repair response in liver as 
early as 2h after dosing (Craddock et^  al., 1976). The repair response is 
probably due to damage exerted on the DNA by formation of 3-methyl
adenine and extremely low levels of 0-6 methyl guanine. Single strand
breaks arising from attack on DNA are thought to be responsible for the
cytotoxic effects of MMS.
It was therefore interesting to observe the effect of intraperitoneal 
injection of MMS at 60mg/kg body weight on nuclear DNA synthesis in 
liver, four hours after i.p. administration of an initial sublethal dose.
Groups of 3 animals were treated as described in section 4.2.4. Analysis
of DNA polymerizing activity in nuclear extracts from treated animals
showed a reduction of over 25% when compared to controls. The total DNA
3
polymerase activity ([ H]dTTP incorporated into polydA.oligodT was 
1337+4 pmol/h/g liver compared to 977+51 pmol/h/g liver in treated 
animals. To investigate the possibility that the reduced activity of the 
enzyme was due to in vivo methylation of proteins by MMS, the response of 
the activity in nuclear extracts isolated from treated animals to in 
vitro treatment with iodoacetamide or N-ethylmaleimide was compared to 
that of control enzyme. Results are shown in table 4.5. No significant 
difference in the response to N-ethylmaleimide was observed. DNA 
polymerase B activity from treated animals appeared slightly more 
susceptible to all concentrations of iodoacetamide used when compared to 
controls. The fidelity of the B polymerase activity isolated from MMS 
treated animals was slightly elevated when compared to controls for
3
[ H]dCTP incorporation into polydA.oligodT (table 4.6). This value is
not however, considered to be significantly different from the controls
as it falls within the range observed for B polymerase activity in normal
3nuclear extracts. No misincorporation of [ H]dGTP into polydA.oligodT 
was observed.
From these results it still remains unclear if the reduction in B 
polymerase activity observed in MMS-treated animals resulted from in vivo 
methylation of protein. If the major site of alkylation in protein is at 
exposed cysteine residues then one would expect lower concentrations of 
thiol reagent to inactivate the 'modified' enzyme ijri vitro. This effect 
has not been observed here.
MMS has also been shown to inhibit replicative or 'S' phase DNA 
synthesis in mammalian cells in culture (Dahle et al., 1978). The
inhibition was not associated with thymidine metabolism but caused a 
reduction in the number of rep1icons actively engaged in DNA synthesis, 
as well as reducing the rate or extent of DNA chain elongation. An 
inhibition of excision-repair of UV-induced pyrimidine dimers in normal 
SV40 transformed human cells has been observed following exposure to MMS, 
post-irradiation (Park et al., 1981). In these two situations it is
possible that inhibition of replication or repair complexes is a direct 
result of their alkylation by MMS.
Thus, if inhibition of DNA polymerase B activity in MMS-treated 
animals is due to protein alkylation, then the site of alkylation must 
provide a relatively large target to the alkylating agent.
Table 4.5
Inhibition of DNA polymerase B activity Isolated from untreated and 
MMS-treated rats by N-ethylmaleimide and iodoacetamide.
N-ethylmaleimide
(mM)
[ H]dTTP incorporation*
treated
(pmol/h) % control
untreated
(pmol/h) % control
0
0.1
0.5
1.0
5.0
10.0
461
441
358
386
286
247
100.0
95.6
77.6
83.7 
62.2 
53.6
548
458
492
421
351
275
100.0
83.6
89.8
76.8
64.1
50.2
Iodoacetamide
(mM)
0 461 100.0 548 100.0
1 582 106,2
10 393 85.2 474 86.5
25 320 69.4 427 77,9
50 357 55.7 345 62.9
100 167 36.2 225 41.1
.3[ H]dTTP incorporated by S^ fractions (25iil aliquots) into
polydA.oligodT in lh at 37°C.
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Effect of in vivo administration of N-N,dialkyInitrosamines on the level
and fidelity of DNA polymerase B activity in nuclear extracts from rat 
liver.
Single, sublethal doses of dialkylnitrosamines are rarely 
carcinogenic unless administered after partial hepatectomy (Craddock, 
1975; Craddock and Henderson, 1979). The doses used in this study were 
chosen to minimize restorative hyperplasia, a response to centrilobular 
liver necrosis (typical of DMN and DEN toxicity).
The amount of DNA polymerase £ activity (total activity for 
equivalent liver masses) at different times after injection are shown in 
figures 4,7-4.10. Results are also expressed in terms of protein 
concentration, although no clear relationship with time was observed here 
possibly due to the inhibitory effects of the nitrosamines on protein 
synthesis (Stewart and Magee, 1971; Villa-Trevino ,, 1967).
Total DNA polymerase £ activity in nuclear extracts from treated 
animals was reduced 2h after dosing for all the nitrosamines when 
compared to controls. Longer alkyl chain lengths seemed to be more 
effective in reducing DNA polymerase activity. After 5h, DNA polymerase B 
activity in DPN- and DBN-treated animals had returned almost to normal 
whereas the. activity in DMN- and DEN-treated animals continued to fall. 
DEN-treated animals showed a 40% increase in DNA polymerase B activity 
compared to controls after 8h. Elevated levels of DNA polymerase B 
activity were also found in DMN-treated animals after 16h. At 24h enzyme 
activity in all groups had returned to the control value.
The fidelity of DNA polymerase B activity in S2 nuclear extracts
from each group of animals at various time points was measured. Results
are shown in tables 4.7 and 4.8. The fidelity of B polymerase activity in
3
control animals was between 1/170 and 1/200 for [ H]dCTP incorporation
into polydA.oligodT at each time point. No change was observed in DPN- or
DBN-treated animals, pooled enzyme samples from DEN-treated animals
showed a 50% reduction in fidelity after 8h, which had returned to a
normal value by 24h. A similar reduction in fidelity was found in pooled
samples from DMN-treated animals, 8h and 16h after injection. No
3
significant amount of [ H]dGTP incorporation into polydA.oligodT was
observed in samples from any group of animals.
Damage to DNA normally elicits a repair response. The nature of 
alkylated bases in DNA formed by nitrosamines likely to stimulate this 
response is shown in figure 1.4. The metabolism of DMN is rapid in vivo. 
At the dose level used here it has been shown that DMN is completely
Legend to figures 4.7.-4.10.
L i v e r s  w e r e  r e m o v e d  f r o m  c o n t r o l  a n d  t e s t  a n i m a l s  2 , 5 , 8 , 1 6  a n d  
24h a f t e r  d o s i n g  w i t h  n i t r o s a m i n e s  o r  v e h i c l e  a l o n e .  DNA p o l y m e r a s e  
fi a c t i v i t y  ( p m o l  [ ? l Q d T T P  i n c o r p o r a t e d / h  i n t o  p o l y d A . o l i g o d T )  w a s  
m e a s u r e d  u s i n g  25 ju l  s a m p l e s  o f  n u c l e a r  e x t r a c t s  ( S d e r i v e d  f r o m  
e a c h  l i v e r r i n  t h e  p r e s e n c e  o f  ImM N - e t h y l m a l e i m i d e . R e s u l t s  a r e  
e x p r e s s e d  a s  a % o f  t h e  a c t i v i t y  i n  c o n t r o l  a n i m a l s  (1 00%  v a l u e s ) 
a n d  r e p r e s e n t  t h e  mean o f  2 r a t s  w h e r e  r e s u l t s  d i d  n o t  v a r y  b y  m o r e  
t h a n  10%.
@------------- © DNA p o l y m e r a s e  a c t i v i t y / g  l i v e r
A  A  DNA p o l y m e r a s e  a c t i v i t y / p g  p r o t e i n .
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Table 4.7.
Fidelity of DMA polymerase J3 activity in nuclear extracts from 
control and N,-N-dialkylnitrosamine treated rats.
Misincorporation of dCTP into polydA.oliqodT.
Time after dosing (h)
Control3 2 5 8 16 24
DMN 1/180 1/170 1/190 1/110 1/120 1/180
DEN 1/200 N.D. 1/210 1/100 N.D. 1/200
DPN 1/200 1/240 1/180 1/200 N.D 1/240
DBN 1/180 1/180 1/390 N.D. N.D. 1/330
Error ratesc
a Mean error rate of control nuclear extracts (S2) at each time point
b N.D. = not determined
c ratio pmol dCTP/pmol dTTP incorporated into polymeric material (mean
of quadruplicate determinations).
Table 4.8.
Fidelity of DMA polymerase B activity in nuclear extracts from 
control and N,-N-dialkylnitrosamine treated rats.
Misincorporation of dGTP into polydA.oliqodT.*
Time after dosing (h)
8 16 24
DMN 1/13000 1/11000 1/14000 1/40000 1/14000
DEN N.D3 1/14000 1/14000 N.D. N.D.
DPN 1/14000 1/14000 1/14000 N.D. 1/14000
DBN 1/14000 1/30000 1/28000 N.D. 1/14000
2
Error rate
1 Mean error rate of control S2 fractions at each time point
was 1/14000 for misincorporation of dGTP into polydA.oligodT.
2 Error rates are the mean of duplicate determinations
3 N.D. = not determined.
metabolized within 6h (Magee et al., 1976). The maximum extent of
alkylation of DMA occurs after about 5h (Craddock and Magee, 1963). 
Longer alkyl chain derivatives are metabolised more slowly (Shank, 1975; 
Montesano and Bartsch, 1976). DEN is metabolised at a rate of 4% of the 
dose per hour in rats (Magee et al., 1976).
The small increase in DNA polymerase B activity observed here, 
following administration of DMN or DEN occurs around the time of maximal 
DNA alkylation by these agents. The increase may be due to activation of 
a pre-existing B polymerase or synthesis of a new enzyme. A similar 
increase in DNA polymerase activity was observed by Stewart and Magee 
(1971) in kidney of rats 2-4h following i.p. administration of DMN 
(40mg/kg body weight). Induction of repair replication is evident in rats 
2h after receiving DMN (30mg/kg body weight) (Craddock et al., 1976). DNA 
polymerase B activity can also be induced in animals after chronic 
treatment with DEN (Craddock and Ansley, 1979).
The DNA polymerase B activity induced here in DMN- and DEN-treated 
rats appears to be error-prone, with an almost 50% reduction in fidelity. 
No appearance of an error-prone polymerase occurs in DPN- and DBN-treated 
animals. This may be associated with the apparent slower metabolism of 
these longer alkyl chain derivatives. Thus production of a certain 
alkylated derivative of DMN or DEN may be responsible for induction of an 
error-prone DNA polymerase.
The reason for the inhibition of DNA polymerase B activity 2h after 
treatment with DMN, DPN and DBN which persists after 5h in DMN- and 
DEN-treated animals is unclear. Inhibition of RNA synthesis in vivo, 
following DMN treatment in mammalian cells (Herzog and Farber, 1976), may 
be due to an identical mechanism. Whether or not this effect is due to 
low level alkylation of protein remains to be investigated.
In summary, in vitro alkylation of DNA polymerase B activity in 
nuclear extracts resulted in a gradual inactivation of the enzyme with 
increasing concentration of alkylating agent. The fidelity of DNA 
polymerase B activity was enhanced after Jji vitro treatment with MMS, 
MNNG or BPL. In vivo studies on nuclear DNA polymerase B activity after 
MMS treatment, failed to show that inhibition of the enzyme was due to 
methylation by MMS. In vivo administration of DMN and DEN appeared to 
induce an error-prone DNA polymerase B activity.
CHAPTER 5
THE EFFECT OF ADMINISTRATION OF BENZO(a)PYRENE 
ON NUCLEAR DNA POLYMERASE B ACTIVITY AND FIDELITY
5.1 INTRODUCTION
The polycyclic aromatic hydrocarbon (PAH), benzo(a)pyrene (V) is a 
ubiquitous environmental chemical which may be one of the most prevalent 
chemical carcinogens to which man is exposed. Significant quantities of 
benzo(a)pyrene (B(a)P) have been found in foodstuffs, cigarette smoke, 
exhaust fumes, emissions from industrial processes, soil and water. (The 
occurrence of B(a)P in the environment is reviewed in the IARC monograph, 
1973).
The causal relationship between exposure to chemicals and certain 
human cancers was first implicated by Pott (1775). Prolonged contact with 
soot was thought to be the cause of scrotal skin cancer in chimney 
sweeps. Since this first observation, a great number of PAH's have been 
shown to have carcinogenic activity; the first to be identified was 
probably dibenzo[a,h]anthracene (Kennaway and Hieger, 1930).
As well as being implicated in the etiology of some human cancers, 
B(a)P and other PAH's can cause cancer in laboratory animals, cell death, 
and mutation and transformation in cultured mammalian cells (Huberman and 
Sachs, 1974). Generation of this biological damage is dependent upon 
metabolic activation of B(a)P to some reactive intermediate (Grover and 
Simms, 1968) which, as is now generally accepted exerts its effect 
through a covalent interaction with a critical cellular macromolecule 
(Miller and Miller, 1966).
Metabolism of Benzo(a)pyrene
The metabolic activation of benzo(a)pyrene in various systems has 
been the subject of many excellent reviews (Yang et_ al., 1978; Gelboin, 
1980), and thus shall only be discussed briefly here. Activation of 
benzo(a)pyrene to its ultimate carcinogenic form occurs via the mixed 
function oxidase (MFO) system which is part of the endoplasmic reticulum 
and consists of cytochrome P450 and an electron transport chain. Other 
enzymes interact with B(a)P subsequent to its initial reaction with MFO 
(including epoxide hydratase (EH), glutathione-S-transferase (GSH-T), 
UDP-glucuronyl transferase (UDPGA-T) and sulphotransferase (ST)), 
yielding a complex series of metabolites (figure 5.1). Over 20 
metabolites have been isolated from intact cells or after in vitro 
exposure of microsomal activating systems to B(a)P (Wislocki e^t al.,
1976). Using a Salmonella typhimurium system, these authors found that
the most highly mutagenic metabolites appeared to be B(a)P-4,5-oxide and
Figure 5.1.
The metabolism of benzo(a)pgrene
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7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BPDE), There 
is much evidence to suggest that BPDE may be the ultimate carcinogenic 
metabolite (Newbold and Brookes, 1976; Kapitulnik et_ al., 1978).
Formation of BPDE from benzo(a)pyrene-7,8-diol is a stereospecific 
process yielding 2 diastereoisomers: diol-epoxide I or 'anti' BPDE
(7B,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tet rahydrobenzo(a)pyrene) 
and diol-epoxide II or 'syn' BPDE (7B,8a-dihydroxy-9B,lOB-epoxy- 
7,8,9,10-tetrahydrobenzo(a)pyrene) abbreviated here as anti(±)BPDE and 
syn(±)BPDE respectively (figure 5.2.). Each diastereoisomer has a (+) and 
(-) enantiomer. Only anti(±)BPDE is significantly mutagenic in mammalian 
cells and has been shown to have exceptional carcinogenic potency in new 
born mice (Kapitulnik et al., 1978). The (+) enantiomer appears to be the 
most potent carcinogen of the four enantiomers as assessed by two-stage 
tumorigenesis systems (Buening et al., 1978; Slaga et al., 1979).
The relatively short life-time of BPDE in vitro (see later) and the 
presence of cytoplasmic detoxification mechanisms has raised the question 
whether metabolic activation by the microsomal MFO system can lead to 
covalent interactions with macromolecules in the cell nucleus. The 
presence of cytochrome P450 species and aryl hydrocarbon hydroxylase 
activity in the nuclear envelope has now been established (Pezzuto et 
al., 1977; Rogan et^  al., 1976). Induction of cytochrome P448 and aryl 
hydrocarbon hydroxylase activity occurs in nuclei of rats treated with 
3-methylcholanthrene (Rogan et al^ ., 1976). Cytochrome P448 is a species 
of cytochrome P450 associated with the metabolism of PAH. The nuclear 
P448 appears identical to that present in the cytoplasm.
Interaction of BPDE with nucleic acids
'Anti' or 'syn' BPDE can be synthesized as a racemic mixture (±) in 
the laboratory (structures VI and VII) (Yagi et al., 1977). Modification 
of synthetic polynucleotides, DMA and RNA in vitro has shown that BPDE 
reacts predominantly at the exocyclic amino group (N-2.) of guanosine by 
cis or trans addition at the C-10 of the hydrocarbon (Straub et al.,
1977). Modification of cytosine and adenosine takes place to a lesser 
extent presumably at the N-4 and N-6 of cytosine and adenine respectively 
(Jennette et al., 1977). Since addition at C-10 of BPDE can be cis or 
trans, the number of possible isomers formed from interactions with 
racemic mixtures of 'anti' or 'syn' diol-epoxides is 8 in vitro (figure 
5.3). The formation of deoxyadenosine-BPDE adducts has also been observed 
in isolated cells and tracheobronchial tissue treated with B(a)P in vitro
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(Ashurst and Cohen, 1982; Autrup et al., 1980). The major hydrocarbon- 
deoxyribonucleoside adducts formed in the skin of mice treated in vivo 
with B(a)P are derived from the reaction of anti(±)BPDE with 
N-2-deoxyguanosine (Phillips et al., 1979). Recently Ashurst and Cohen 
(1981) have reported the presence of deoxyadenosine adducts in mouse skin 
(accounting for 2-3% of the total adducts formed) arising from cis or 
trans addition of the exocylic amino group (N-6) of deoxyadenosine to the 
7R form of BPDE. Gamper et al. (1977) have obtained evidence that BPDE 
may also modify phosphate residues of the nucleic acid backbone. No 
evidence for this reaction in vivo has yet been obtained. Similarly, it 
has been postulated that BPDE interacts at N-7 of guanine but the 
instability of this product has made its identification difficult 
(Osborne jet al., 1978; King et al., 1979). There appears to be a high 
degree of stereospecificity in tissues metabolizing benzo(a)pyrene (in 
many systems so far studied it appears that there is preferential 
synthesis of the 7R-BPDE from B(a)P-7,8-diol (Thakker et al., 1977)). The 
biological activities of anti(±)BPDE and syn(±)BPDE may be dependent on 
their relative stabilities. Measurements of the half-life of the 'syn' 
and 'anti' forms of BPDE by Wislocki et al. (1976) indicate that the 
former has a half-life of less than 30s and the latter of 2-13min in 
aqueous environments in vitro. The reason for the low stability of 
syn(±)BPDE is probably due to the presence of the 7-hydroxyl group cis to 
the 9,10-oxide ring which thus facilitates opening of the oxide ring. 
However these observations may not be a good indication of the situation 
in vivo since non-covalent interaction of the diol-epoxides may occur 
with hydrophobic carrier proteins thus extending the half-life (Weinstein 
et al. 1978). With the exception of a metabolite in mouse skin (in vivo) 
derived from 9-hydroxybenzo(a)pyrene (Ashurst and Cohen, 1981), no 
covalent binding to DNA by any other metabolite of B(a)P has been shown 
to date. Non-covalent interactions (intercalation) of B(a)P-7,8-diol and 
B(a)P-7,8,9-triol however have been observed by Kakefuda et al. (1980). 
The importance of these observations will be discussed in section S\3,
Interaction of BPDE with protein
Despite the early observation of Miller (1951) of binding of PAH to 
protein, most emphasis has been on the study of PAH interaction with
tAj
nucleic acids. However, MaCleod et al. (1979) have shc^ h that the majority
of macromolecular binding in hamster embryo cell (HEC) cultures treated
3 3
with [ H]B(a)P is to protein. Treatment of HEC cultures with [ H]
anti(±)BPDE resulted in labelling of both histones and to a lesser 
extent, non-histone proteins in chromatin (MaCleod et al., 1980; 1981). A 
specific non-histone protein from HeLa cells has been shown to bind BPDE, 
yet its identity remains obscure (Whitlock, 1978). The nature of covalent 
bonds between PAH and protein have not yet been discovered. Non-covalent 
interactions are also thought to occur between histones and BPDE, with 
the diol-epoxide accomodated in hydrophobic regions of the protein 
(Whitlock, 1978).
Repair of BPDE adducts in DNA
The major repair system which operates in mammalian cells for the 
removal of BPDE adducts to DNA appears to be nucleotide-excision repair 
involving long-patch repair analogous to UV excision-repair (see chapter 
1). In normal fibroblasts it appears that deoxyadenosine and
deoxycytidine adducts are repaired more efficiently than N-2 
deoxyguanosine adducts (Kaneko and Cerutti, 1982; Cerutti et al., 1978). 
The reason for this is probably associated with distortional effects
caused by each adduct on the DNA helix. When BPDE interacts with
deoxyguanosine in double-stranded DNA, the pyrene moiety is thought to be 
located in the minor groove of the helix, causing minimal distortion,
leading to lack of recognition by excision enzymes (Nordenskjold et al.,
1978). Adducts at the N-6 position of adenine however result in major 
distortion of the helix since complementary base-pairing between adenine 
and thymine is almost completely disrupted, such that this site of damage 
would be more readily recognized by repair enzymes (Kakefuda and 
Yamamoto, 1978).
Excision-repair of N-2 deoxyguanosine adducts has been shown to be 
relatively error free in vitro (Yang et al., 1980). However due to the 
persistence of these adducts in DNA cell cultures (Feldman et al., 1978) 
a post-replication repair mechanism is also postulated to be involved in 
the response to DNA damage caused by BPDE (Waters et al., 1978). However, 
the nature of the products inserted opposite damaged sites has not been 
elucidated. The mechanism by which single-strand breaks, postulated to be 
formed in DNA after the interaction of BPDE at N-7 of guanine and N-3 of 
adenine (Haseltine et_ al., 1980) and also by the reaction of 6-oxo-B(a)P 
(an oxidized form of 6-hydroxy B(a)P, Nagata et al., 1974) are repaired 
has not been elucidated.
The aim of the studies presented in this chapter was firstly to 
determine the nature of adducts formed by 3ji vitro interaction of BPDE
with polydA.oligodT and to measure the fidelity of rat liver DNA 
polymerase B in copying template:primer thus modified. The effect of in 
vitro modification of DNA polymerase B activity by BPDE on the fidelity 
of DNA synthesis and whether the effects observed in vitro could be 
mimicked by in vivo administration of B(a)P to rats were also assessed.
5.2 MATERIALS AND METHODS
5.2.1 Materials
Anti(±)BPDE was synthesized by R. Smith at Shell Research Ltd., 
Sittingbourne. Benzo(a)pyrene-7,8-diol; benzo(a)pyrene-9,10-diol and 
3-hydroxy-benzo(a)pyrene were kindly provided by Dr. S. W. Ashurst. 
Benzo(a)pyrene, venom phosphodiesterase I (type VII), spleen 
phosphodiesterase II (type I), P^ nuclease and alkaline phosphatase 
(type III) were purchased from Sigma. PolydG.oligodC^.^Q was ^rom PL 
Biochemicals. Sephadex LH-20 was from Pharmacia. All other chemicals used 
were as listed in previous chapters.
5.2.2. Modification of polydA.oligodT and polydeoxyadenosine by 
anti(t)BPDE
All manipulations involving anti(±)BPDE were performed under subdued 
lighting.
PolydA.oligodT (0.25mg) was dissolved in 50% (v/v) aqueous ethanol 
(0.2ml). Anti(±)BPDE (O.lmg) in 0.1ml tetrahydrofuran (THF) was added and 
samples were incubated overnight at 37°C in the dark under nitrogen. 
After incubation samples were evaporated to near dryness on a rotary 
evaporator, and 1.0ml H^O added. The aqueous solution was then 
extracted repeatedly with diethyl ether until no more tetrol was observed 
in the ether layer (UV absorbance of ether layer measured in the range 
200-370nm. A typical tetrol spectrum is shown in figure 5.6). The final 
ether layer was removed and the aqueous layer was heated for 5min at 
100°C to remove non-covalently bound BPDE and tetrols. On cooling, 
the modified polymer was precipitated by addition of ice-cold ethanol and 
centrifuged at 2000rev/min for 20min in a Sorvall RC2-B centrifuge. The 
supernatant was discarded and the pellet was resuspended with ice-cold 
ethanol and re-centrifuged. The washed pellet was finally resuspended in 
lOmM Tris-HCl pH 7.2, containing lOmM MgCl2 (0.5ml) and treated with 
400units DNAase I; 0.006units (venom) phosphodiesterase I*, 0.88units 
(spleen) phosphodiesterase II and 80yg P^  nuclease. The reaction 
mixture was incubated overnight at 37°C (in the dark). Finally, 
alkaline phosphatase (20units) was added and incubation continued for a 
further 24h at 37°C. The reaction mixture was then evaporated to 
dryness using a rotary evaporator and the residue resuspended in 1.0ml
aqueous methanol (30% v/v). Reaction conditions for polydeoxyadenosine
were identical except that lmg polydeoxyadenosine was used and all other 
reagents and enzymes were increased in the same proportions.
5.2.3. Sephadex LH-20 chromatography
Methanol extracts containing modified polynucleotides were applied to 
a 70cm x 1.6cm Sephadex LH-20 column equilibrated with aqueous methanol 
(30% v/v), and elution was with a 30-70% (v/v) linear methanol gradient 
(Baird and Brookes, 1973). 100 x 10ml fractions were collected and the UV 
absorbance of each fraction at 260nm was measured on a Pye-Unicam SP-8 
400 UV/visible spectrophotometer. Adduct containing fractions were 
combined, evaporated to dryness and resuspended in small volumes of 50% 
(v/v) aqueous methanol for HPLC analysis.
5.2.4. HPLC analysis of LH-20 adduct containing fractions
An Altex HPLC system was used throughout these studies (supplied by 
Beckman, U.S.A.), fitted with a Pye-Unicam LC-UV detector. A Rheodyne 
injector (model 7125) fitted with a 2ml sample loop was used to inject 
samples. The column was an Ultrasphere ODS (250mm x 4.6 mm) 
reversed-phase column. Samples, (20-100yl) were injected onto the 
column and eluted with a linear gradient of 45-50% (v/v) aqueous methanol 
for 20min, held isocratic for 30min and eluted with a linear gradient of 
50-60% methanol for a further 20min. The flow rate was 0.6ml/min for
50min, changed to l.Oml/min for the remaining time (Panthananickal and 
Marnett, 1981).
5.2.5. In vitro modification of polydA.oligodT and polydG.oliqodC by 
anti(t)BPDE for determination of the effect on DNA synthesis by 
DNA polymerase B
Stock solutions of 4mM BPDE in dry THF were prepared less than lh 
before use and stored in the dark. Stock solutions of polydA.oligodT
(O.lmM) and polydG.oligodC (0.2mM) were prepared in 0.1M NaCl/50mM 
Tris-HCl buffer, pH 7. Duplicate 200yl samples of template were 
incubated in the dark for 4h at 37°C in the presence of 0-20yl of 
BPDE solution. The total volume was made up to 220yl by addition of THF 
and the final concentration of anti(±)BPDE was 0-400yM. Template
incubated in the presence of THF only was used as the control (100%
activity). Aliquots of reacted template (60yl) were then used in the
DNA polymerase B assay as described in section 3.2.
5.2.6. In vitro modification of DNA polymerase B activity in nuclear 
extracts from rat liver by metabolites of B(a)P
The general method used for modification of DNA polymerase B activity 
is described below. Minor changes in the methodology are described were 
appropriate, in section 5.3.
Stock solutions (1-lOmM) of 3-hydroxy B(a)P, B(a)P-7,8-diol, 
B(a)P-9,10-diol, anti(±)BPDE, B(a)P and B(a)P-7,8,9,10-tetrol were 
prepared in dry THF. Duplicate, 500yl samples of nuclear extract 
(UF^ ) from normal rat liver (prepared as described in section 3.2.) 
were incubated for lh at 37°C in the dark, with 0-27.5yl of each
metabolite solution. The total volume was made up to 550yl with
distilled water. Enzyme samples treated with equivalent volumes of
distilled water and THF, were treated identically to test samples and 
served as controls (100% activity). Aliquots of modified or 
'mock-modified' enzyme (25yl) were tested for DNA polymerizing activity 
and fidelity on polydA.oligodT as described in section 3.2.
5.2.7. In vivo administration of benzo(a)pyrene
Weight-matched male Wistar albino rats (180-200g) were used
throughout the course of this study. Animals had access to food and water 
ad libitum. Six groups of 4 test animals and 4 control animals were dosed 
intraperitoneally with 50mg/kg body weight benzo(a)pyrene in corn oil, on 
day 0, between 8:30 a.m. and 9:30 a.m.. Control animals received
equivalent volumes of corn oil only. Animals were killed by cervical 
dislocation at approximately 9:00 a.m. 1,3,5,7,10 and 14 days after dosing
A seventh group of animals received 50mg/kg body weight B(a)P in corn 
oil on day 0 and again on day 1. Controls received equivalent volumes of 
corn oil only each day. All animals in this group were killed 24h after 
receiving the second dose.
Liver samples (7g) were removed from each animal and immediately 
washed in ice-cold 0.3M sucrose. Nuclei and nuclear extracts were
isolated as described in section 3.2. The total amount of DNA polymerase 
B activity per g liver was measured in the presence of ImM
N-ethylmaleimide and the fidelity of DNA polymerase B activity was
measured as described in section 3.2.
5.2.8. Determination of nuclear cytochrome P448 activity
Ethoxyresorufin O-deethylase activity in P2 nuclear fractions 
(section 3.2.) from test and control animals was measured using the 
method of Burke and Mayer (1974) using a Perkin-Elmer MPE-3 
spectrophotofluorimeter.
5.3 RESULTS AND DISCUSSION
Effect of in. vitro modification of template by anti(t)BPDE on DNA 
polymerase B activity
PolydA.oligodT was gradually inactivated by increasing concentrations 
of anti(±)BPDE, only retaining 40% of the control activity when modified 
by 360yM anti(±)BPDE (table 5.1.). Inactivation of the template was not 
due to non-covalent interaction of B(a)P-tetrols since similar 
concentrations of tetrol had no effect on DNA polymerase B activity 
(table 5.2). Although polydG.oligodC is not a good template:primer for 
DNA polymerase B, it was similarly inactivated by anti(±)BPDE (table 
5.1). Slightly higher inactivation of polydG.oligodC was achieved at 
lower concentrations of anti(±)BPDE when compared to polydA.oligodT. This 
is probably due to the higher reactivity of anti(±)BPDE with 
deoxyguanosine (Jennette et al., 1977).
The fidelity of rat liver DNA polymerase B in nuclear extracts, 
copying polydA.oligodT modified by 90yM and 180yM anti(±)BPDE was not 
altered, when compared to mock-modified controls (table 5.3). Fidelity 
studies could not be performed on modified polydG.oligodC as the activity 
of DNA polymerase B on unmodified template was extremely low, such that 
any misincorporations could not be detected using this system.
The hydrocarbon-deoxynucleoside adducts formed following the reaction 
of anti(±)BPDE with polydA.oligodT were isolated following enzymic 
hydrolysis (Brookes and Lawley,1971), by Sephadex LH-20 chromatography 
and HPLC. Reaction products were compared to those obtained in a reaction 
of polydeoxyadenosine with anti(±)BPDE. The UV absorbance (260nm) of 
fractions eluted from LH-20 Sephadex by increasing concentrations of 
aqueous methanol is shown in figure 5.4. Adduct-containing fractions were 
eluted in fractions 52-90 for polydA.oligodT and slightly earlier for 
polydeoxyadenosine (fractions 46-58). High pressure liquid chromatographic 
analysis of the adduct-containing fractions from polydeoxyadenosine 
yielded nine major peaks (figure 5.5). Early eluting material in 45-50% 
(v/v) aqueous methanol was probably unmodified nucleoside (peak A). Peaks 
B and C eluted in the same position as marker tetrols (see appendix). 
Peaks D, E, F and G eluted in the same position as marker deoxyadenosine 
adducts (prepared from a large scale reaction between anti(±)BPDE and 
DNA, and identified by circular dichroism and UV spectral analysis, 
(Watson W. and Smith R. J., manuscript in preparation). Peaks D, E, F and 
G corresponded to N-6 deoxyadenosine adducts with configurations 7-R
Table 5.1
Effect of in vitro modification of template:primers by anti(t)BPDE on DNA 
synthesis by DNA polymerase B in rat liver nuclear extracts
(a) polydA.oligodT
3
BPDE [ HjdTTP incorporation DNA polymerase activity*
(uM) (pmol/h) (% of rontrol)
0 (control) 652 100
45 . 668 102
90 594 91
180 442 68
360 265 41
k k
(b) polydG.oliqodC
3
BPDE [ H]dCTP incorporation DNA polymerase activity
(yM) (pmol/h) (% of control)
0 (control) 4.0 100
45 3.9 99
90 3.1 80
180 1.8 45
350 1.2 29
* 3
Activity = pmol [ H]dNTP incorporated per h into
template:primer at 37°C by 25yl of nuclear extract.
Assay conditions using polydG.oligodC were identical to 
polydA.oligodT conditions except that reaction mixture contained 
20yM each of dCTP, dGTP, dTTP and dATP and the specific 
activity of [^HjdCTP was 282 d.p.m/pmol.
Table 5.2
Interaction of tetrols (derived from anti(t)BPDE) with polydA.oligodT.
tetrol
(jiM)
[ H]TTP incorporation 
(pmol/h)
DMA, polymerase activity 
(% of control)*
0 (control) 
18 
45 
90 
180
995
949
906
947
871
100
99
95
99
91
Notes:
Tetrol (benzo(a)pyrene-7f8,9,10-tetrahydro-7,8,9,10-tetrol) was 
formed by hydrolysis of anti(+)BPDE at 60°C in an acetone :THF 
:water (3:1:3) mixture (see appendix). After evaporation of solvent, 
the tetrol was resuspended in THF at a concentration of 2mM and
2-20yl fractions were incubated in the presence of polydA.oligodT 
(200yl) for 4h at 37°C. (Controls (100% activity) were 
incubated with THF only). Samples (60yl) of template:primer taken 
through this procedure were then tested for ability to support DMA 
synthesis by rat liver nuclear extracts. Results are mean of 
duplicate determinations.
* see table 5.1.
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trans, 7-S cis, 7-S trans and 7-R cis respectively. Peak F' was not
identified. The UV spectrum of the 7-S-trans adduct fraction from a 
polydeoxyadenosine-anti(±)BPDE reaction is shown in figure 5.6. Peaks 
derived from adduct fractions show a red shift when compared to the 
corresponding tetrol peaks.
The elution order of peaks after HPLC of polydA.oligodT LH-20 adduct
fractions was the same as for the polydeoxyadenosine-anti(±)BPDE
reaction. An additional peak, however was observed eluting after 15min. 
The identity of the hydrolysis product(s) in this peak is unknown (figure 
5.7). Peaks D^ , E^ , F^ and probably corresponded to the 7-R
trans, 7-S cis, 7-S trans and 7-R cis adducts at N-6 deoxyadenosine
respectively. The slightly faster elution times observed for 
polydA.oligodT derived peaks were probably due to slight variations in 
HPLC conditions when compared to polydeoxyadenosine-derived peaks. 
Insufficient material was available for UV spectral analysis.
The reaction of anti(±)BPDE with DNA, polyA and polydeoxyadenosine in 
vitro, yielding the adducts described here has been observed by Jeffrey 
et al. (1979), Kinoshita et al. (1982) and Meehan et al. (1977). 
Deoxyadenosine adducts have also been isolated after in vivo treatment of 
mouse skins with B(a)P (AShurst and Cohen, 1981). The reaction occurs 
between the exocyclic amino group (N-6) of deoxyadenosine and C-10 of 
BPDE. Jeffrey et al^. (1979) have suggested that in vitro, DNA and 
polydeoxyadenosine react preferentially with the 7-S form of BPDE. This 
is not the situation in vivo, due presumably to the stereospecificity of 
the metabolism of B(a)P (Yang elb al., 1976). Ashurst and Cohen (1981) 
have shown that deoxyadenosine residues in DNA react with the 7-R form of 
BPDE in vivo by trans addition to a greater extent than by cis addition. 
The major adduct formed in these studies appeared to be derived from 7-R 
addition to the N-6 of deoxyadenosine in both homopolymers.
The in vitro inhibition of DNA synthesis observed here with modified 
polydA.oligodT and polydG.oligodC is in agreement with the in vitro 
studies of DNA synthesis on synthetic template:primers using avian 
myeloblastosis virus (AMV) reverse transcriptase and E.coli DNA
polymerase I, which showed that the rate of synthesis decreased with 
increasing modification of template (Yamaura et al., 1981 and 1978). 
Similar inhibition of RNA polymerase (E.coli) on modified DNA in. vitro 
has also been observed (Weinstein et al., 1978). If synthesis was allowed 
to continue in these cases, the final product reached almost the same
size as the product of DNA synthesis on mock-modified templates, thus
indicating that these enzymes can by-pass adducts in the template. BPDE
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deoxynucleoside adducts in DNA are generally repaired by a nucleotide 
excision-repair mechanism which is relatively error-free. 
Post-replication repair or a by-pass repair mechanism must also exist in 
vivo. Evidence supporting this has been obtained by Rinaldy et al. (1982) 
who showed that replication of BPDE-modified SV-40 virus in mammalian 
cells is delayed but the cells eventually overcome blockage to synthesize 
high molecular weight DNA. Excision-repair defective xeroderma 
pigmentosum cd!s can also overcome BPDE lesions in DNA, again by a 
by-pass mechanism (Waters et al., 1978). However, the presence of
deoxyadenosine-BPDE adducts in polydA.oligodT does not lead to enhanced 
misincorporation by rat liver nuclear DNA polymerase B (table 5.3). 
Similarly misincorporation was not observed by Yamaura et al.. (1978) 
during DNA synthesis by AMV reverse transcriptase on polyrC.oligodG.
The effect of the presence of deoxyadenosine-BPDE adducts in DNA is 
not understood. DiGiovanni et al. (1979) have suggested that binding of 
PAH to polyA but not to polyG, mediated by epidermal homogenates 
correlates with the carcinogenic potencies of the parent hydrocarbons on 
mouse skin in vivo. Kakefuda and Yamamoto (1978) have shown that binding 
of BPDE to deoxyadenosine in DNA causes local denaturation and unwinding 
of the DNA helix. Clusters of adenines have been found near to promotor 
regions in bacteria and to initiation sites in plasmids. Perturbation of 
these structures may alter binding and recognition by DNA and RNA 
polymerases.
Effect of in vitro modification of rat liver DNA polymerase B by 
anti(±)BPDE
The reaction of DNA polymerase B with B(a)P-7,8-diol, B(a)P-9,10-diol, 
3-hydroxybenzo(a)pyrene, B(a)P-tetrols and unmetabolized B(a)P did not 
significantly reduce the ability of DNA polymerase B to incorporate
3
[ H]dTTP into polydA.oligodT at concentrations less than 50yM (tables 
5.4 and 5.5). Some inhibition of the enzyme (approximately 20%) was 
observed on exposure to lOOyM B(a)P-7,8-diol, B(a)P-9,10-diol and 
3-hydroxybenzo(a)pyrene. Preliminary studies had shown that DNA 
polymerase B activity in nuclear extracts was completely inhibited by 
concentrations of anti(±)BPDE between 10-lOOyM (table 5.6). The 
concentration of solvent (tetrahydrofuran) used in these experiments was 
not responsible for the complete inactivation of the enzyme since 
mock-modified controls were inhibited by approximately 50% in the 
presence of the highest concentrations of THF. These results were not
table 5.4
Effect of tetrols derived from anti(t)BPDE on DMA polymerase B activity 
In rat liver nuclear extracts.
3
Tetcol [ H]dTTP Incorporation
(yM) (c.p.m./h)
0 2685 ± 108
10 3044 ± 126
25 2850 ± 607
50 2969 ± 351
100 3224 ± 122
Results are the mean of 4 determinations ± S.D. using polydA.oligodT 
as template:primer.
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table 5.6
In vitro modification of DNA polymerase B activity in nuclear extracts by 
anti(t)BPDE.
3
anti(t)BPDE % THF in nuclear [ H]dTTP incorporation 
(pM) extract (pmol/h)
test control
0 0 765 765
10 0.5 10 757
25 1.25 7 744
50 2.5 9 717
100 5.00 12 382
Results are the mean of duplicate determinations.
reproducible with subsequent batches of enzyme (table 5.7). Enzyme 
exposed to increasing concentrations of anti(±)BPDE up to 500yM was 
gradually inhibited to 50% of the control mock-modified activity. The 
concentration of THF was maintained at 5% (v/v) in all enzyme samples
(tests and controls). This effect was reproducible.
The reason for the partial inactivation of the enzyme is not
apparent. Nuclear magnetic resonance (MMR) spectral analysis of the 
anti(±)BPDE sample used in these studies (see appendix) did not indicate 
the presence of any hydrolysis products of BPDE. Precipitation of a 
proportion of anti(±)BPDE on addition of the THF solution to the aqueous 
enzyme solution was ruled out since this effect was not observed in
template modification studies. Further experimentation will be required 
on purified DNA polymerases to clarify this observation.
3
Misincorporation of [ H]dCTP into polydA.oligodT by 
anti(i)BPDE-modified DNA polymerase B appeared to be reduced when 
compared to mock-modified controls (table 5.8). An increase in fidelity 
of over 10-fold was observed using DNA polymerase B modified in vitro by 
lOOyM anti(±)BPDE. This effect was reproducible and is similar to that 
reported in section 4.3 for the in vitro modification of DNA polymerase B 
by alkylating agents. A similar effect has been observed by Chan and 
Becker (1980) after in. vitro modification of DNA polymerase a from 
regenerating rat liver by N-acetoxyacetylaminofluorene and by Yamaura et 
al. (1978) using AMV reverse transcriptase. The mechanism of the 
increased fidelity is not understood. Mildvan and Loeb (1979) have 
postulated that nucleotide selection may be affected by alteration of the 
local dielectric constant at substrate and template binding sites such 
that the tautomeric equilibria of the bases are shifted from incorrect to 
correct forms, thus enhancing the fidelity of the DNA polymerization 
reaction.
Effect of in vivo administration of benzo(a)pyrene on DNA polymerase B 
activity in rat liver nuclei
Total DNA polymerase B activity was not significantly altered when 
compared to controls 24h after a single injection of 50mg/kg body weight 
B(a)P. Significant reductions in DNA polymerase B activity were observed 
at 3 days and 7 days and persisted until day 14 (table 5.9). The specific 
activity during this time reached a maximum value on day 5 after an 
initial drop in the first 3 days and had returned to control values by
day 14 (table 5.10). The fidelity of pooled enzyme fractions at each time
Table 5.7
In vitro modification of DNA polymerase B activity in nuclear extracts by 
anti(t)BPDE
anti(t)BPDE DNA polymerase activity*
(jjM) Experiment 1* Experiment 2* Experiment 3*
0 519 ± 48 (100) 650 + 36 (100) 458 (100)
1.0 . _ 428 (94)
2.5 - 352 (77)
5.0 - 330 (72)
10.0 383 ± 5 (74) -
25.0 309 ± 15 (60) -
50.0 312 ± 26 (60) 345 + 20 (53) -
100.0 265 ± 5 (51) 470 + 24 (72) -
200.0 343 + 8 (66) 467 + 33 (72) -
300.0 - 412 + 20 (63) -
500.0 - 373 + 21 (57) —
Experiments performed using different preparations of nuclear 
extract.
3
[ H]dTTP incorporated into polydA.oligodT (pmol/h). Values are 
the mean of quadruplicate determinations ± S.D. except 
experiment 3 (results are the mean of duplicate determinations).
Figures in parentheses denote % of the control (100% activity).
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Table 5.9
Total DNA polymerase B activity in nuclear extracts after treatment In 
vivo with benzo(a)pyrene
Days after 
treatment
1
Total DNA polymerase 8 activity
in_S2 fraction
test control
Nuclear cytochrome 
P448 activity^ 
test control
1 59.8 + 6 (4) 61.9 + 1 (4) 0 0
3 50.7 ±
*
7 (4) 57.4 + 2 (4) 129 ± 13 0
5 61.1 + 8 (3) 64.5 ± 5 (4) 0 0
7 57.8 ±
**
6 (4) 70.2 ± 5 (3) 0 0
10 74.9 i 2 (3) 82.6 ± 8 (4) 0 0
14 72.2 +
*
2 (3) 80.6 ± 5 (3) 0 0
Notes:
nmol [ H]dTTP incorporated into polydA.oligodT per h at 
37°C for equivalent liver masses.
pmol resorufin formed per min per mg protein by P2 nuclear 
fractions. The limit of detection of resorufin was 114pmole
Using Student's t-test with P < 0 . 1
**
Using Student's t-test with P <0.05
Figures in parentheses denote number of animals used in each 
experiment.
Table 5.10
Specific activity of DMA polymerase B In nuclear extracts after treatment 
in vivo with benzo(a)pyrene
Days after Specific activity* of DNA Specific activity
treatment polymerase B (% of control)
test control
1 99 + 18
*
99 + 21 99
3 75 + 8
**
91 ± 13 86
5 116 + 13 91 ± 10 128
7 104 + 11 112 + 1 94
10 122 + 15 133 + 15 92
14 121 + 10 128 + 11 95
Notes:
c.p.m. incorporated into polydA.oligodT per h at 37°C per
yg protein in Sp fraction,
Using Student's t-test with P < 0 . 1
'k'k
Using Student's t-test with P <0.05
Results are based on the mean of 4 animals per group except in 
control animals on day 7 and day 14 (3 animals per group).
point was measured using polydA.oligodT as template-.primer. Results are 
shown in table 5.11. The fidelity in test animals did not differ 
significantly from controls. Error rates for test animals ranged from 
1/270 to 1/580 and for control animals ranged from 1/250 to 1/510 for the
3
misincorporation of [ H]dCTP.
Administration of 2 doses of B(a)P (50mg/kg body weight), 48h and 24h 
before killing resulted in an increase in total nuclear DNA polymerase B 
activity with a concurrent increase in specific activity (table 5.12). 
The fidelity of the induced enzyme, measured in pooled nuclear extracts 
from test animals, was not significantly different from that in controls 
(table 5.11).
Administration of B(a)P induces microsomal cytochrome P448 activity
almost immediately after i.p. injection and the activity is persistent
for at least 6 days (Conney et al., 1957).Thus it is likely that
metabolism of B(a)P continues throughout this period. Nuclear cytochrome
P448 activity was detected only in nuclei 3 days after animals had
received a single injection of B(a)P (table 5.9.). This coincided with
the inhibition of DNA polymerase activity observed in these studies.
Since DNA polymerase B has been implicated as the repair polymerase
(section 1.4) an activation or induction of the enzyme would be expected
to occur in response to damage arising in DNA due to the reaction with
metabolites of B(a)P. The increase in specific activity observed here
after administration of 2 x 50mg/kg body weight B(a)P to rats would
suggest induction of this enzyme, however the extent of this change does
not seem indicative of de novo synthesis of enzyme but may be due to
activation of pre-existing enzyme.
In order to investigate if the elevation in specific activity
observed in animals on day 5, and in animals which had received 2 doses
of B(a)P was due to appearance of a new polymerase B activity, the
and V of control and test DNA polymerase B activities in nuclear
max r 1
extracts was measured.
Values of K and V derived from Lineweaver-Burk plots of 1/v 
m  ^ roax
(reciprocal of pmol [ H]dTTP incorporated into polydA.oligodT per h per
yg protein) against 1/S (reciprocal of dTTP concentration, yM) are
shown in table 5.13. The K and V values of DNA polymerase Bm max ^ 1
activity in nuclear extracts from animals killed 1 day and 3 days after 
receiving 50mg/kg B(a)P did not differ from controls. However, in samples 
obtained from animals killed on day 5 the K of DNA polymerase B was 
reduced by 46% when compared to controls. A similar reduction in was 
observed in animals which had received 2 doses of B(a)P. Slight
Table 5.11
Fidelity of DNA polymerase B activity In nuclear extracts Isolated 
from control and benzo(a)pyrene treated rat liver.
Days after 
t reatment
dTTP incorporation 
(pmol)
dCTP incorporation Error rate 
(pmol)
test
control
776
755
1.71
1.77
1/450
1/430
test
control
604
627
1.16
1.24
1/520
1/510
test
control
528
739
1.11
1.49
1/480
1/500
test
control
580
793
2.11
3.01
1/280
1/260
10 test 
control
491
482
0.85
1.27
1/580
1/380
14 test 
control
511
483
1.41
1.24
1/360
1/390
1* test 
control
640
564
2.35
2.30
1/270
1/250
Results are the mean of duplicate determinations except in day 7 
samples (mean of quadruplicate values).
* animals received 2x50mg/kg body weight B(a)P.
Table 5.12
Effect of repeated administration of benzo(a)pyrene on the amount of DNA 
polymerase B activity in nuclear extracts.
tests (n=4) controls (n=3)
Total DNA polymerase B 
activity*
Total activity
(% of control) 124.6 100.0
Specific activity of
DNA polymerase B^ 144.4 ± 4 121.4 ± 14
Specific activity
(% of control) 119.0 100.0
1 3nmol [ H]TTP incorporated into polydA.oligodT per h at
37°C by equivalent liver masses.
c.p.m. incorporated into polydA.oligodT per h at 37°C per 
yg protein in S2 fraction.
ft ft
Using Student's t-test with P <0.01
45.1 ± 4** 36.2 ± 4
Table 5.13
Values of K and V_... for DNA polymerase B activity in nuclear ---------- m max-------- — 1---------------- 1----------
extracts isolated from normal and benzo(a)pyrene treated rats.
(a) After 50mg/kq benzo(a)pyrene
Days after 
treatment
V1max
test control
K2m
test control
1 27 29 154 182
3 28 25 182 182
5 20 29 100 182
7 10 14 77 111
10 n.d. n.d. n.d. n.d.
14 n.d. n.d. n.d. n.d.
(b) After 2 x 5Qmg/kg benzo(a)pyrene
2
20 26 100 182
Notes:
1 3pmol [ H]TTP incorporated per h into polydA.oligodT per yg
protein by nuclear extracts ^  fraction).
TTP (yM)
n.d. = not determined.
reductions in were also observed. Further experimentation will be
required to determine if these changes are due to a new species of DNA 
polymerase B activity or due to alteration of existing DNA polymerase 
activity, possibly as a result of B(a)P metabolite binding.
Administration of B(a)P in vivo or B(a)P or BPDE to cell cultures in 
vitro results in an inhibition of replicative DNA synthesis (Waters et 
al., 1978; Rinaldy et al^ ., 1982; Yang et al., 1982; Bowden et al., 1982). 
The block in DNA synthesis is thought to be due to the presence of bulky 
DNA adducts which prevent hydrogen bonding with complementary bases. 
Leffler et aJL (1977) have shown that during replication of calf thymus 
DNA (modified in vitro by anti(±)BPDE) E.coli DNA polymerase remains 
attached to the template when it encounters an adduct and reinitiation at 
another site does not occur. The extent of inhibition is dependent upon 
the extent of exposure to carcinogen. Bowden e^t al. (1982) have recently 
shown that at low doses of BPDE the inhibition of DNA synthesis in Vero 
(African green monkey) cells was due to inhibition of synthesis of 
sub-replicon sizes of DNA whereas at higher doses, inhibition was due to 
an inhibition of joining of replicons to produce longer DNA chains. This 
suggests that the inhibition effect may not only be due to the formation 
of DNA adducts but also due to an inhibitory effect on the proteins 
involved in the replication complex, associated with gap-filling.
Cerutti et al. (1978) have shown that after treatment of mouse embryo 
fibroblasts and baby hamster kidney cells with BPDE, removal of adducts 
from DNA was complete after 72h yet this accounted for only 80% of the 
adducts. Thus some replication must occur, of DNA containing adducts 
either by some replicative by-pass or by an error-prone repair system. 
Rinaldy et al. (1982) showed that after infection of mammalian cells with 
BPDE-modified SV-40 virus, after the initial block to replication most 
DNA molecules were able to replicate yet progeny particles suffered a 
loss in viability. Pulkrabek et al. (1979) similarly showed that 
increasing modification of a plasmid DNA by anti(±)BPDE resulted in a 
decreasing ability of the plasmid to transfect a receptive E.coli strain 
to antibiotic resistance, indicating a persistent defect in 
transcription. However, the studies here did not show the appearance of 
an error-prone DNA polymerase and modification of DNA polymerizing 
activity in vitro did not lead to an increase in error frequency.
The persistent depression of total DNA polymerase B activity after 
treatment with a single dose of B(a)P is difficult to explain 
particularly with the observed increase in specific activity of the 
enzyme after 5 days. Metabolism of B(a)P in known to occur for at least 6
days following administration of low doses of B(a)P (between 0.1 and 
l.Omg per animal) and the effect is expected to be of a longer duration 
after higher doses (Conney et a^ L., 1957). Baird and Diamond (1977) have 
shown that the major DNA adduct formed in hamster embryos cell cultures 
after treatment with B(a)P is derived from syn BPDE after 4-6h but 
between 24-72h is from anti BPDE. Both isomers have a very short 
half-life in vitro, but in vivo, the half-life is dependent on the 
microenvironment. The effective half-life may be increased by the 
non-covalent interaction of the reactive intermediate with hydrophobic 
regions in proteins. Such an interaction has been shown to occur in vitro 
between PAH and histone proteins (Whitlock, 1978). If this occurs in 
vivo, less carcinogen is made available for interaction with DNA and 
other proteins in the short-term, but would result in the carcinogen 
being more persistent in the cell.
Since many nucleophilic centres are exposed for the reaction with 
carcinogens, it is likely that binding of B(a)P metabolites in vivo will 
be random. However, there is some evidence that anti(±)BPDE reacts to a 
greater extent with rapidly renaturing DNA sequences (Jack and Brookes, 
1980). These authors have also shown that initial binding to DNA occurs 
preferentially on linker DNA compared to nucleosomal core DNA (Jack and 
Brookes, 1981). Similarly, Whitlock (1978) has indicated a preferential 
reaction of BPDE in vitro with a specific non-histone protein which is 
associated with core particles. A similar specific effect on DNA 
polymerase B could also account for the persistent depression of activity 
which is observed here.
In summary, In vitro modification of polydA.oligodT by anti(±)BPDE 
resulted in the formation of deoxyadenosine adducts which were
tentatively described as the 7-R trans, 7-S cis, 7-S trans and 7-R cis 
addition products at the N-6 exocyclic amino group of adenine. No
misincorporation of non-complementary nucleotides was observed on 
modified templates although enzymic activity was severely inhibited. In
vitro modification of DNA polymerase B activity resulted in inhibition of
the enzyme but no decrease in fidelity was observed. No error-prone DNA 
polymerase activity was observed following in vivo administration of 
B(a)P. The depression of total DNA polymerase B activity in rat liver 
nuclear extracts observed up to 14 days after administration of a single 
dose of B(a)P was speculated to be the result of a covalent interaction 
of BPDE with the enzyme in vivo, analogous to the situation observed in 
vitro.
CHAPTER 6
FINAL DISCUSSION AND CONCLUSIONS
The absolute fidelity of any mammalian DNA repair process in living 
cells is difficult to evaluate due to the complexity of the mammalian 
genome. However, some insight into the fidelity of DNA repair may be 
gained by the use of in vitro assay systems in which the fidelity of 
individual enzymes associated with DNA repair, copying DNA templates of 
defined base composition can be measured. In the studies described here, 
the DNA template used in fidelity assays of DNA polymerase £ was 
polydA.oligodT since adenine and thymine do not readily hydrolyse into 
products that miscode during DNA synthesis. The use of templates 
containing cytosine, which undergoes spontaneous deamination at 37°C, 
leads to the spontaneous generation of a high background in DNA 
polymerase fidelity assays.
The fidelity' with which isolated DNA polymerases copy a defined 
template may be enhanced in the presence of accessory proteins (Kunkel et 
al., 1979). The use of isolated DNA polymerases may therefore not reflect 
the true accuracy of these enzymes in vivo, due to a sequential loss of 
factors affecting fidelity through the purification procedure. In order 
to overcome this problem, nuclear extracts from adult rat liver nuclei 
were used as a source of DNA polymerase activity.
There were several advantages in using adult rat liver cell nuclear 
extracts. Since these cells undergo very litle, if any cell replication, 
their nuclei contain almost exclusively DNA polymerase fl, the putative 
mammalian repair enzyme. These extracts were found to have no DNA 
polymerizing activity on endogenous DNA templates. Also, since the liver 
is the major site of metabolism of a great number of genotoxic agents, it 
was an ideal system to study the effect of these compounds following 
administration either in vitro or in vivo. Nuclear extracts could be 
quickly and routinely isolated from rat liver nuclei, without the need 
for complicated and lengthy purification procedures.
DNA polymerase fidelity and DNA repair may be important factors in 
the carcinogenic process; hence in the present study, the effect of 
various genotoxic agents on DNA polymerase B in rat liver nuclear 
extracts was investigated, in an attempt to understand the mechanisms by 
which these compounds exert their deleterious effects in vivo.
The fidelity of DNA polymerase B activity measured in normal rat
liver nuclear extracts was low (1/200 - 1/800) when compared to the
fidelity of purified enzymes such as calf thymus DNA polymerase a and
E.coli DNA polymerase I (1/2900 and 1/6600 respectively) for the
3misincorporation of [ H]aCTP into polydA.oligodT (chapters 2 and 3). 
The distributive nature of the polymerization reaction catalysed by DNA
polymerase B is thought to be the reason for the almost 10-fold
difference in fidelity observed between these enzymes and the type a 
DNA polymerases (Loeb and Kunkel, 1982). However, the overall low level 
of fidelity observed for DNA polymerase B may support the theory that in 
vivo a high level of mismatch repair exists which, cannot be detected 
using this assay system.
Following treatment of nuclear extracts isolated from normal nuclei 
with the direct-acting alkylating agents MMS, BPL and MNNG, a
dose-dependent inhibition of DNA polymerase B activity was observed
(chapter 4). An increase in fidelity of DNA polymerase B was also noted. 
Also, a similar increase in fidelity was observed following in vitro
treatment of DNA polymerase B with anti(±)BPDE (chapter 5). The mechanism 
of this action is unclear but Mildvan and Loeb (1979) have suggested that 
agents which can increase the local dielectric constant at substrate and 
template binding sites may shift the tautomeric equilibria of bases to 
the correct form, thus enhancing the fidelity of base selection. It is 
unlikely that this effect can occur in vivo since the local concentration 
of these agents is unlikely to achieve the extent achieved in vitro.
An inhibition of DNA polymerase B activity was similarly observed in 
vivo following administration of MMS to rats (Chapter 4). Cox et al. 
(1976) have shown that following low doses of MMS, alkylated DNA is 
rapidly repaired. However, the inhibition of DNA polymerase activity 
observed in the present study may be due to inactivation of the DNA 
polymerase by methylation.
The. major products of DNA alkylation by MMS are 7-methyl guanine and
3-methyl adenine (Lawley 1976). The presence of these alkylated bases in 
DNA is thought to stimulate DNA repair enzymes. The absence of this 
result (Chapter 4) may also be due to inhibitory effects of MMS on de novo 
enzyme synthesis. The major alkylated base formed in DNA following DMN 
administration has also been shown to be N-7 methyl guanine. Yet DMN and 
agents such as MNNG, which alkylate DNA by an SN^ mechanism, are more 
potent carcinogens than MMS, suggesting that site specific alkylation may 
be an important factor contributing to the carcinogenicity of these 
compounds (Loveless, 1969; Abbot and Saffhill, 1977). The effect of in 
vivo administration of a series of N,-N-dialkylnitrosamines on DNA 
polymerase B activity in rat liver nuclei was therefore investigated.
The initial depression in the total DNA polymerase B activity and 
specific activity which occured 2h after dosing in all 
nitrosamine-treated rats when compared to controls, may have been due to 
inactivation of DNA polymerase B activity by alkylation of the protein
(chapter 4). Since longer chain-length nitrosamines are metabolized more 
slowly than the corresponding diethyl- and dimethyl-nitrosamines (Shank, 
1975) it was surprising that DBN administration showed the greatest
inhibitory activity at this time. It can be speculated that alkylation 
by bulky butyl groups inactivated DNA polymerase B more readily than
alkylation by shorter alkyl chains. Perhaps this point can be clarified 
by the use of an in vitro microsomal activating system in conjunction 
with the DNA polymerase B assay.
Total DNA polymerase B activity and specific activities were elevated 
above control values after 5h in DPN- and DBN-treated animals. The
induced DNA polymerase B activity however was not error-prone, in
contrast to the activity induced or possibly activated in DMN- and
DEN-treated rats. The appearance of the error-prone DNA polymerase B 
activity was short-lived and it was impossible in these studies to
determine whether the error-prone activity was the result of de novo 
enzyme synthesis or due to activation of a pre-existing enzyme. Certainly 
in the case of DEN-treated animals, there was no increase in specific
activity coinciding with the increase in total DNA polymerase activity, 
which would have implicated de novo protein synthesis.
Radman et al. (1978) have hypothesized that error-prone DNA repair is 
stimulated by the presence of overlapping areas of DNA damage or by the 
presence of bulky lesions in DNA which block normal DNA synthesis. This 
hypothesis was tested using the polycyclic aromatic hydrocarbon B(a)P. In 
vitro, the presence of bulky adducts derived from the reaction of 
anti(±)BPDE (the proposed ultimate carcinogenic form of B(a)P) and
deoxyadenosine, were shown here to block DNA synthesis by DNA polymerase 
B in rat liver nuclear extracts using polydA.oligodT, in agreement with 
the results obtained by other research groups (chapter 5). Also, the 
presence of these modified bases did not lead to enhanced
misincorporation of deoxynucleotides by normal DNA polymerase B i_n vitro.
Repeated administration of B(a)P in vivo appeared to result in the 
induction of DNA polymerase B activity (Chapter 5). In animals which 
received only a single dose of B(a)P, total DNA polymerase activity was 
depressed below that of control rats for up to 14 days. In vitro
modification of normal DNA polymerase B by anti(±)BPDE produced an 
apparently saturable 50% inhibition of the enzyme. The depression
observed in vivo may be the result of such a modification but the 
mechanism of the persistent effect is unclear.
The Km value of DNA polymerase B activity in nuclear extracts
isolated from animals treated with B(a)P for 2 days was reduced by almost
50% when compared to the control enzyme activity. A similar reduction in 
Km was observed in DNA polymerase B isolated 5 days after
administration of a single dose of B(a)P. However, despite the appearance 
of this altered enzymic activity, no change in DNA polymerase B fidelity 
was observed in any group of animals treated with B(a)P when compared to 
the untreated rats. The absence of a detectable error-prone DNA 
polymerase B in these nuclei may be associated with the relative 
resistance of rat liver to polycyclic aromatic hydrocarbon-induced 
carcinogenesis (Ashurst,1980).
The inhibitory effects of alkylating agents and anti(±)BPDE on DNA 
polymerase B observed In vitro may have profound consequences in. vivo. A 
similar inhibition of other DNA repair enzymes in the repair complex will 
result in an effective reduction in the rate of DNA repair, and it is 
therefore possible that a proportion of DNA damage will not have been 
removed before replication begins. Replication of damaged regions may 
lead to mutation, or cytotoxicity if the damage poses a block to DNA 
replication or transcription. At the present time, there is no evidence 
to suggest that DNA polymerase B is structurally unique, allowing 
specific attack by anti(±)BPDE. The concentration of anti(±)BPDE which 
inhibited DNA polymerase B by 50% in vitro was 100 fold lower than the 
concentration of alkylating agents required to exert this effect; this 
may be a significant factor in the mode of action of this carcinogen in 
other tissues. The extent of reaction Tn vivo of B(a)P and other 
alkylating agents with DNA polymerase B and other DNA repair enzymes 
should be further investigated with the use of radiolabelled carcinogens.
Many theories have been proposed in an attempt to understand the 
carcinogenic process. The somatic mutation theory, originally proposed by 
Boveri (1914) and later revived by Burdette (1955) is based on the 
hypothesis that tumours arise as a consequence of permanent alterations 
in the base sequences of DNA in normal somatic cells. The mutant cells 
have proliferative advantages over normal cells and eventually become 
dedifferentiated. Attack on DNA itself is often considered to be the only 
means of achieving a heritable change which would lead to neoplastic 
growth.
Alterations in base sequence may arise during DNA polymerization by 
an error-prone DNA polymerase acting on normal or carcinogen-modified 
DNA; or base modifications in DNA, which have evaded normal DNA repair 
processes may be inaccurately copied by DNA polymerases. In the latter 
case, due to tautomerization or ionization of bases, DNA polymerases may 
incorporate a base into DNA where the physico-chemical interaction may be
correct thermodynamically even though mispairing has occured in the 
Watson-Crick base-pairing sense (Singer and Kusmierek, 1982). It is
uncertain if alkylated bases may also be incorporated into normal DNA in
this way. Recently, Klopman and Ray (1982) have shown that base pairs 
formed between 0-6 methyl guanine and thymine; 0-4 methyl thymine and 
guanine, and 0-2 methyl thymine and guanine, are actually more stable
than the complementary counterparts. Thus misincorporation in these cases 
may occur even in the absence of an error-prone polymerase. A scheme has 
been proposed by Loeb et al. (1974) based on the hypothesis of Nelson and 
Mason (1972), in which progressive errors in DNA synthesis arising as a 
result of altered DNA polymerase fidelity, are causally related to 
malignant alterations. A summary of the hypothesized events leading to 
tumour progression is shown in figure 6.1. At the present time, there is 
very little information regarding the stimulus for error-prone DNA 
polymerase activity. Many DNA polymerases with differing properties from 
the normal enzymes have been detected in tumours (Roychoudhury and Bloch, 
1969; Ove e^t al., 1969), however there is little evidence that these 
enzymes copy DNA with altered fidelity except in the case of a DNA
polymerase a which appears during N-2-acetylaminofluorene-induced 
carcinogenesis (Chan and Becker, 1980).
Models for an epigenetic theory of carcinogenesis have been proposed 
by Pitot and Heidelberger (1963), based on the gene regulation theory of 
Jacob and Monod (1961), in which the carcinogenic state arises due to 
errors in gene expression. They suggested that the reaction of a 
carcinogen with a target protein could lead to an altered but stable 
metabolic situation, without the necessity for any direct interaction of 
the carcinogen and genetic material. This could arise by binding of the 
carcinogen to a specific repressor protein. The inhibitory action of 
carcinogen binding to DNA polymerase B has been demonstrated here. In 
this respect, binding of carcinogens to allosteric sites on other 
non-histone proteins may alter gene expression leading to neoplastic 
growth. A more detailed examination of the interaction of chemical 
carcinogens with nuclear proteins may prove fruitful since the 
introduction of errors into DNA at a low level may not have profound 
consequences, since genes exist in multiple copies and this may act as a 
cushion to repair or replicative errors.
It has emerged from the present studies that the in vivo 
administration of sub-lethal doses of genotoxic agents induces either a 
normal DNA polymerase B activity (in DBN-, DPN-, and B(a)P-treated rats)
or an error-prone DNA polymerase (DEN- and DMN-treated rats). Isolation
Figure 6.1.
Consequences of the accumulation of errors in DNA synthesis.
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(After Loeb et al.(1974).
and amino acid sequence analysis of the new error-prone DNA polymerase 
activity will be necessary in order to determine if this enzyme is a new 
gene product or a product of post-translational processing of a 
pre-existing protein. It is also feasible that the error-prone activity 
may arise indirectly, as a result of interaction of carcinogens with 
information handling molecules such as RNA polymerases, amino-acyl tRNA 
synthetases and tRNA anticodons. It can be envisaged that minor 
modifications such as those induced by short alkyl chain derivatives, may 
alter the activity of these molecules whereas addition of. bulky groups, 
such as those derived from B(a)P adducts or longer alkyl-chain 
derivatives, may simply inactivate these molecules. These possibilities 
must also be tested using in vitro translation systems. Finally, it is 
unlikely that the error-prone activity arises as a result of alkylation 
of DNA polymerase B since in vitro alkylation rapidly inactivated this 
enzyme and no decrease in fidelity was observed.
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APPENDIX
A p p e n d i x  1
P u r i t y  o f  [_^H~\dMTPs u s e d  i n  f i  d e l i t u a s s a y s
R a d i o a c t i v e  dNTPs w e r e  a p p l i e d  t o  p o l y e t h y l e n e  i m i n e  c e l  1 u l o s e  F 
p l a t e s  as  d e s c r i b e d  i n  s e c t i o n  2 . 2 . 9 .  P l a t e s  w e r e  d e v e l o p e d  i n  2M 
L i  C l  : 2M f o r m i c  a c i d  ( 1 : 1 ) .  The p o s i t i o n  o f  r a d i o a c t i v e  p e a k s  w a s  
d e t e r m i n e d  b y  r a d i o c h r o m a t o g r a m  s c a n n i n g .
£
 __________  __    s o l v e n t
^  I f r o n t
V
'£75 s. y. . £~
1^'. ^  V-r f  i
>v O '  - —
v'
e-t.
s-
y-K ~
*5—  s-
F~ >
fc 9  ^ ^
F  5- ^
J    ^  - -   -^.origin
£
dTTP dGTP dCTP
D e v e l o p i n g  t i m e :  
Sc a n  s p e e d  :
R f  dTTP  
R f  dGTP 
R f  dCTP
90 mi  n 
300mm /h
=  0 . 5 2 3  
= 0 . 3 3 1  
=  0 . 5 7 5
360MHz P r o t o n  S p e c t r u m  o f  a n t i ( ± ) B P D E  
S o l v e n t  : d i m e t h y l  s u l p h o x i d e
Appendix 2.
Appendix 3.
HPLC e l u t i o n p r o f i l e o f  B ( a ) P  t e t r o l
HPLC c o n d i t i o n s  : s e e  s e c t i o n  5 . 2 . 4 .
E l  u t i  on  t i  me o  f  
m a j o r  p e a k s  : P e a k  1 4 2 . 3 m i n
Pe a k  2  5 2 .  8mi  n
Appendix 3.
OEcte
O'I00CL Cj£
Appendix 4.
360mHz P r o t o n  S p e c t r u m  o f  B ( a ) P - t e t r o l  
S o l v e n t  : d i m e t h y l  s u l p h o x i d e
»-■■■-i',!. >  : • •: -  j h -| •:.■•!
I •-r .1 !-••i-i-:'-. j .
-r;-’• f
• ' t-r ”—i ! Appendix ;v ; " : ; ' ;
;■]’:• i-vi.'t : vi: :;;:; ■ 'j
1 •; }',■ 
i■M • •’  ; r •• l  \
- J. A
s .- r: : v-y-n !■;■• l-S-j-i* ' I ;— rj--7:— j— ;■
ti:L;t4 ' i
^ p': -
a-1-..;...;.
. i,.;-.: i-i. ■[. j- • . i -  :-••■■'■•! '••"!• ., •
»•— i— i-T1 ...  .. 'T " :  1— -r- r ••» - — •* 7 - V
: . W 4  ■
J., , r j,, j r
. . . i 1 
; 1.1 j ;\j!: -■ ■+- 1
i • i
- : - i  - i l - ’ h  . f
..'I lI ';i
V-y .i :~y\L:vi [;i J i l l ;
’ ’ • ! ! ' !  ' ! • '  i '  "  ’i i  H  : !  11-’  - I • • ! •  • : : • ! '
y^-isyyq?1t'
*:Tl:i^ r‘
Appendix 5
3
The Effect o£ Protein Concentration on the Retention of [ H]-labelled 
polynucleotides on DE 81 cellulose discs.
DNA polymerase assays were set up as described in section 3.2 using a 
nuclear extract from normal rat liver nuclei as a source of DNA 
polymerase activity, with a protein concentration of less than lrag/ml. At 
the end of the incubation, 10-200yg BSA was added to lOOyl samples of 
DNA polymerase reaction mixture, and the mixture applied to DE 81 discs. 
Discs were washed as described in section 2.2.6(b). Control incubations 
did not contain BSA and blanks did not contain template.
Test Blank
BSA (c.p.m. retained c.p.m. retained (c.p.m. retained
(yg) on DE 81 discs) (% of control) on DE 81 discs)
0 2061 100 37
10 2205 ± 84 107 37
20 1952 ± 112 95 32
50 2079 ± 275 101 36
100 2024 ± 147 98 30
200 2147 ± 89 104 37
■k
mean of 4 determinations ± S.D.
